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Towards High Field Body MR
Since Goldsmith et al. performed the first successful body Magnetic Resonance Imaging 
(MRI) scan in 1977 (Figure 1) much effort has been put into improving the (diagnostic) 
quality of body MR images. This improvement has been realized through enhanced 
gradient systems, receive/transmit coils, and pulse sequences, as well as, increased field 
strength of the MR systems. By increasing the field strength of the MR scanner a larger 
effective magnetization of the spins is produced resulting in an increase in the signal-to-
noise ratio (SNR). Furthermore, with increasing field strength, the contrast of the images 
change, specifically when using contrast agents, creating new scanning possibilities.
Radio Frequency Coils, SENSitivity Encoding, GeneRalized Autocalibrating Partial 
Parallel Acquisition) at higher field strength.1–3 Due to the changes in contrast at higher 
field imaging, an increased efficacy of contrast agents, such as gadolinium (percentage T1 
reduction due to gadolinium is higher), makes higher field strength more suitable for 
dynamic contrast enhancement (DCE) scans. Furthermore, functional neuroimaging can 
benefit of an increased Blood-oxygen-level dependent contrast (BOLD) response due to 
stronger spin-spin interaction (lower T2*) enabled by a stronger magnetic field.4,5 In MR 
spectroscopy, separation of the resonance frequencies improves due to an increased 
chemical shift resulting in improved spectral quality and specificity.
Challenges for High Field Body MR
Despite these clear advantages of higher field scanners, clinical body imaging is still 
predominantly performed on 1.5 T MR scanners since the advantages previously 
described are not yet fully translated to clinical practice.
The main reason for this is the increase in imaging artefacts often accompanied by a 
higher magnetic field strength. Such artefacts are often caused by an increase in; 
transmit field (B1
+) inhomogeneities (dielectric effects), static field (B0) inhomogeneities, 
motion artefacts (respiratory, cardiac and bowel) and susceptibility effects. When 
comparing field strengths of 1.5 T and 3 T in cardiac functional imaging, Michaely et al 
(2006) observed only a minimal increase in SNR at 3 T.6 Greenman et al. (2003) reported 
that blood suppression was comparable between 1.5 T and 3 T systems in cardiac 
imaging.7 However, a decrease in SNR was found in the myocardial wall for 3 T compared 
to 1.5 T. This decrease in SNR was mainly attributed to the variance in the B1
+ field. 
Furthermore, studies comparing 1.5 T to 3 T often report an increase in imaging arte-
facts.8 Specifically artefacts caused by increased sensitivity to motion and increased 
magnetic susceptibility, but also B1
+ field inhomogeneities are observed.9,10
Another important factor to consider when moving from 1.5 T to 3 T is that the Specific 
Absorption Rate (SAR) will be four times higher since this is quadratically related to the 
magnetic field strength.11,12 This could complicate transferring a scan sequence from 1.5 T 
to 3 T since the radio frequency (RF) heating limits can be reached and changes have to be 
made to stay within the SAR constraints.6 
All these challenges clearly demonstrate that it is complicated to fully exploit the theoret-
ical advantages of higher field strengths. Additionally, the purchase and maintenance cost 
of high field scanners are significantly higher. Therefore, if these challenges are not 




As mentioned in the previous paragraph, transmit field inhomogeneity is a major contrib-
utor to artefacts with increasing field strength. These artefacts represented by hyper and 
hypo intense areas in the image (Figure 2). This inhomogeneous B1
+ field results in signal 
voids in the image and has been reported by multiple researchers.8,13–16 As stated by 
Bernstein ‘‘Image shading and uneven contrast resulting from spatial variation in the 
transmit B1 field remains one of the biggest unsolved problems for routine clinical 3 T 
imaging today”.8 This inhomogeneity is even more prominent in patients with ascites but 
also in pregnant women resulting in these populations to be scanned at lower field 
strengths (1.5 T). 
FIGURE 1: First MRI body image recorded by Goldsmith et 
al. By today’s standards this image has an extremely low 
(coarse) resolution, however, basic structures like the 
heart and lungs are visible in the image. 
High Field Advantages
In the early days, when Goldsmith recorded his first body MR image, field strengths of the 
scanners were well below 0.5 Tesla (T). In the following years, the field strength of clinical 
body MR scanners increased to 1.5 T increasing SNR and thereby improving image 
quality. 
In the last decade, high field scanners (defined as  3 T) are increasingly used in clinical 
practice. High field systems are favoured over 1.5 T systems for multiple applications 
because of the higher SNR it provides. The additional SNR can be used to increase the 
resolution for imaging smaller structures (pathologies). Alternatively, the increase in SNR 
allows for a reduction in scan time by lowering the number of signal averages (NSA). 
Furthermore, high field systems can reduce acquisition time even further due to 




When looking at an unloaded birdcage coil the transmit field is very homogeneous for 
both the 1.5 and 3 T scanners. However, when a lossy object like the body is placed in the 
coil, the disturbance introduced by the body will cause the transmit field to be less 
homogeneous. This disturbance of the field is caused by a shortening of the wavelength in 
the body as well as attenuation of the transmit field. This is often referred to as the 
standing wave effect which becomes problematic when the wavelength of the transmit 
signal is equal or smaller than the size of the object imaged (wavelength in muscle tissue 
at 3 T ≈ 29cm). Both the wavelength as well as the attenuation is dependent on the field 
strength, with a more severe disturbance at higher field strength scanners.
MR manufacturers recognize the problem of B1
+ inhomogeneities and are addressing it by 
using multi transmit set-ups. Such a multi transmit splits the standard quadrature body 
coil in effectively two (or more) linear transmit coils that can be independently driven with 
an optimized phase and amplitude. The two degrees of freedom (relative amplitudes and 
relative phases of the two channels) compared to only one (absolute amplitude) for a 
conventional single transmit system can produce considerable increases in RF transmit 
homogeneity 17,18 which has long been known theoretically and investigated extensively for 
imaging at ultra-high field (7 T).19–21 Despite improved performance with dual-channel 
systems, it does not consistently solve the problem of image inhomogeneities. Experi-
mental and simulation work has suggested that further improvement is possible using an 
eight channel transmit body coil, but such a setup is currently not commercially avail-
able.22,23
A second approach to address the issue of transmit field inhomogeneity in 3 T body 
imaging is the use of ‘‘dielectric pads’’.24–27 Dielectric materials have a strong impact on 
the magnetic field. The extent of this effect is determined by the shape and material 
properties (specifically permittivity and conductivity) of these dielectrics. When a dielec-
tric material is carefully designed it can be used to correct the inhomogeneous RF field to 
make it more homogeneous. Furthermore, it can increase the receive sensitivity, result-
ing in increased SNR. Previously these pads were made from ultrasound gel (low relative 
permittivity, µr  100) with dissolved paramagnetics, such as manganese chloride, to 
provide a short T2 and hence low background MR signal. Some institutions reported that 
such dielectric pads are used locally for most abdominal scans 25, whereas others report 
that they are not commonly used in the wider community.8 Recently it was proposed that 
new high dielectric materials, including calcium titanate and barium titanate, would have 
more freedom in shaping the transmit field.28,29 Furthermore, compared to the pads made 
of low permittivity materials, these pads can be made thinner which facilitates their 
application (Figure 3). 
FIGURE 2: (A) T1-weighted turbo-spin echo image at 3 T 
with clear image hypo and hyper intensities caused by an 
inhomogeneous transmit field. 
(B) The corresponding transmit field map shows a low 
transmit field in the areas were the T1-weighted image has 
strong hypo intensities.
FIGURE 3: Example of a high dielectric pad placed on the 
liver. With this high dielectric pad it is possible to shape 
the transmit field to make it more homogeneous.
MR Spectroscopy
MR spectroscopy is a technique often used in research applications in body MR since it 
enables assessment of metabolites in the body. Instead of measuring the (water) proton 
densities (as in MR imaging) it is possible to measure separate metabolites and to 
quantify the abundance of such a metabolite. Commonly measured metabolites are 
triglyceride and creatine which play an important role in various diseases (e.g. metabolic 
syndrome and cardiovascular disease).30–33 
However, as in MR imaging, it is challenging to translate MR spectroscopy to higher field 
scanners. Challenges such as an increase in transmit field (B1
+) in-homogeneities, static 
field (B0) inhomogeneities, motion artefacts (respiratory, cardiac and bowel) and suscep-
tibility effects previously described, apply here as well. In several MR spectroscopy 
studies it has been shown that the potential benefits (increased SNR, better metabolite 
separation) are not fully utilized. For example, in brain spectroscopy a comparison 
between 1.5 T and 3 T Barker et al. (2001) showed an increase in SNR of only 28% and 6% 
of the N-acetylaspartate signal, where a gain of 100% would be expected.34 In a second 
study comparing 1.5 T and 3 T spectroscopy, in both patients with mild cognitive impair-
ment and patients with Alzheimer disease, there was no advantage in diagnostic value 
when using a higher field strength.10 Both studies acclaimed the lower SNR gain to 
broader linewidths stressing the need for better static magnetic field (B0) shimming 
methods at higher field. Another study that measured myocardial lipids showed an SNR 
gain of 76% for in-vivo and 45% for ex-vivo measurements, also not reaching the theoreti-
cal 100% SNR gain of doubling the scanner field strength. This suboptimal increase in 
SNR was also attributed to B0  inhomogeneity as well as an increase in susceptibility and 
motion artefacts.35
Overall, body MR spectroscopy can be a challenging technique to perform specifically on 
high field scanners. This can also be seen from the studies that were performed to test 




variation) ranged from 3.6% to 10% while in the heart it ranged from 6.5% to 18%. This 
shows that that the reproducibility of spectroscopy varies strongly between organs but 
also between studies themselves. No studies evaluating the reproducibility of renal 
1H-MR spectroscopy for detection of renal triglyceride content had been performed prior 
to this thesis.
MR spectroscopy background
To understand why MR spectroscopy can be challenging to perform, specifically at high 
field, some background information is needed. By placing an object in a strong external 
magnetic field the protons in the object will align with the direction of this field. The 
protons will also precess (rotate around the magnetic field direction) at a frequency 𝜔0 
that depends on the strength of the magnetic field 𝐵0 as well as the gyromagnetic ratio 𝛾.
	 𝜔0	=	𝛾𝐵0   (Equation 1)
The gyromagnetic ratio 𝛾 is a constant and is 42.6 MHz/T for hydrogen protons. In an 
average clinical scanner with a field strength of 1.5 T the hydrogen protons will precess at 
64 MHz. To interact with the protons in the object an RF pulse with the same frequency as 
the precession frequency (resonance frequency) of the protons is transmitted. The 
magnetization of the protons then rotates from the longitudinal plane into the transversal 
plane. When the RF pulse excitation ends, the magnetization of the protons will slowly 
return to their natural state in the direction of the applied magnetic field. During this 
relaxation process the object transmits a signal which can be measured by the MR 
scanner. By applying a Fourier transformation, the received signal is transferred from 
time domain into its separate frequency components.
Chemical shift
As mentioned before protons will precess at a frequency described by equation 1. 
However, if all protons would always precess at the same frequency we would see only 
one single peak in the MR spectroscopy frequency spectrum not allowing us to discrimi-
nate between different metabolites. However, the precession frequency is not solely 
dependent on the applied magnetic field and the gyro-magnetic ratio. There is also a third 
component that describes the amount of electrons surrounding (chemical environment) 
the protons. The electrons surrounding a proton will shield it from the external magnetic 
field thereby lowering the precession frequency of the proton. The effect of shielding of 
the electrons can be expressed in a shielding constant 𝜎 and can be applied to equation 1 
to determine the effective precession frequency.
	 𝜔0	=	𝛾𝐵0(1	−	𝜎)	 	 (Equation 2)
The phenomena that protons experience a different magnetic field dependent on their 
chemical environment is called chemical shift. In MR spectroscopy we can exploit this 
property to discriminate between different metabolites which have different chemical 
environments. When an MR spectroscopy experiment is performed the received signal 
(after Fourier transformation) will consist of multiple peaks with each peak representing 
protons in a certain type of environment. Figure 4 displays an example of a liver spectrum 
that consists of multiple peaks that represent different metabolites. Generally, the 
chemical shift is expressed in parts per million (ppm) by dividing the precession fre-
quency (in Hz) by the field strength of the scanner to create an output independent of the 
scanner field strength. Some structures, like triglyceride, consist of multiple moieties 
each with their own chemical environment and thus, resonance frequency. The most 
prominent resonances of triglyceride are CH3 (0.9 ppm), (CH2)
n (1.3 ppm), CH2CH = CHCH2 
and CH2COO (2.1 ppm). By quantitatively measuring the concentrations of triglyceride in 
organs, assessment of cellular damage from lipotoxicity can be performed. Moreover, 
proton MRS enables measurement of metabolites involved in the energy supply of the 
body such as creatine (3 ppm). Furthermore, the amount of water (4.7 ppm) can be 
measured which is often used as an internal reference to quantify other metabolites.
Even though MR spectroscopy is one of the few techniques that enables quantification of 
various metabolites in the body, clinical applications are currently limited to neurology, 
and more recently, the prostate.43–45 Body MR spectroscopy applications are still 
restricted to the research domain due to the fact that it is a challenging technique to 
perform reliably. This is due to problems described earlier such as transmit field fluctua-
tions, static field fluctuations as well as an inherent low SNR of the metabolites of 
interest.
Clinical applications of high field body MR - Metabolic Syndrome
Data of the International Diabetes Federation (IDF) shows that a quarter of the world’s 
adult population meets the criteria for Metabolic Syndrome (MetS).46 The IDF defined 
metabolic syndrome as “a cluster of the most dangerous risk factors including diabetes 
and prediabetes, abdominal obesity, high cholesterol and high blood pressure” increasing 
the risk of serious health problems like diabetes, heart failure, non-alcoholic liver 
disease, renal failure and stroke.47 
•	 Raised plasma triglyceride level;  150 mg/dL (  1.7 mmol/L)
•	 Reduced plasma HDL cholesterol;  40 mg/dL (1.03 mmol/L) in males and  50 mg/dL  
(  1.29 mmol/L) in females
•	 Raised blood pressure; systolic BP  130 or diastolic BP  85 mm Hg
•	 Raised fasting plasma glucose;  100 mg/dL (  5.6 mmol/L) 
FIGURE 4: Example MR spectroscopy (single voxel) mea-
surement in the liver with an elevated triglyceride water 
ratio (  5%) compared to a healthy liver. The two images 
show the measurement location (white voxel) in the trans-
verse and coronal direction. On the right the MR spectrum 
is shown with resonances of triglycerides (0.9, 1.3, 2.1 ppm) 




Due to the globally increasing prevalence of obesity, as well as higher life expectancy, 
MetS is increasingly diagnosed as it is correlated with elevated body mass index as well 
as advancing age. 
Although the exact underlying cause of MetS is still not fully understood, insulin resist-
ance is considered to be a significant factor in the development of MetS. Insulin is a 
hormone which is produced by beta-cells in the pancreas to facilitate uptake of glucose 
from the blood into tissue such as liver, kidney and muscle cells. When the body becomes 
less sensitive to insulin, the uptake of glucose from the blood is reduced, resulting in high 
blood glucose levels. To compensate for these increased blood glucose levels, the 
beta-cells increase insulin production. This in turn increases the load on the beta-cells 
until the maximum insulin production is reached and glucose builds up in the blood. This 
effect is labelled hyperglycemia and is linked to excessive triglyceride levels in parts of 
the body including the liver, skeletal muscle, and heart, and renal tissue. Such raised 
lipids levels, described as ectopic fat deposition, interfere with cellular function and can 
cause cell death through a phenomena known as lipotoxicity, which plays an important 
role in the pathogenesis of MetS (Figure 5).30,48
Hallmarks of MetS in the heart, liver and kidney
A description of the full extent of the impact of MetS on the body is beyond the scope of 
this thesis and therefore, we focused on the three primarily affected organs; the heart, 
liver and kidney.
In the heart elevated myocardial triglyceride content has been linked to an increased 
chance of heart failure.49,50 As shown in animal studies, increased storage of myocardial 
triglyceride reflects an abundance of toxic lipids that impair cardiomyocyte integrity and 
function. Myocardial steatosis may be an early sign of diabetic cardiomyopathy, because it 
is an independent predictor of diastolic dysfunction. 
In the liver, the blood glucose is converted into glycogen or fatty acids which serve as an 
energy source. However, when excessive glucose is present in the blood, it will be 
converted to vacuoles of triglyceride lipid and stored in the liver cells. This process is 
called hepatic steatosis and is diagnosed in case a liver biopsy shows that more than five 
percent of the hepatocytes contain vacuoles of triglyceride lipid. If hepatic steatosis is not 
treated it can progress to non alcoholic steatotic hepatitis (NASH), characterized by 
inflammation of the hepatocytes. A quarter of patients with NASH develop fibrosis 
(scarring of the liver tissue).51 In a subgroup of these patients, NASH eventualy results in 
cell death of the hepatocytes (necrosis) which often necessitates a liver transplant. 
How MetS, in particular obesity, can lead to incipient chronic kidney disease remains 
unclear. Recently ectopic lipid accumulation in the kidney (fatty kidney) has been pro-
posed as a potential pathway.52–55 Notably, obesity and type 2 diabetes have been associ-
ated with renal lipid accumulation in both human and porcine kidneys with differences in 
anatomical distribution between glomeruli and tubuli, as well as the cortex and 
medulla.53,56 Increased renal lipid content has also been linked to functional and struc-
tural renal hyperfiltration, obesity-related glomerulopathy, and type 2 diabetic nephropa-
thy.52,56-57. Various rodent models have shown that intervention in cellular lipid pathways 
attenuated obesity-related glomerulopathy or diet-induced chronic kidney disease.58
At present, MetS is diagnosed by a cluster of the most dangerous risk factors. Several 
organizations have described such criteria (eg. IDF, WHO, ADA) and even though these 
diagnostic criteria are not the same they often include factors like prediabetes, abdominal 
obesity, high cholesterol and high blood pressure. However, these criteria provide limited 
information to what extent the different organs are affected. To improve treatment 
strategies, organ-specific (imaging) biomarkers are needed to gain more insight in the 
underlying mechanisms and risk stratification of MetS. Since many disease pathologies 
related to MetS are believed to be closely correlated to the increased storage of lipids in 
the organs, shown to be a precursor for lipotoxicity, a reliable technique to measure the 
amount of ectopic lipids in the organs is highly needed.
FIGURE 5: Extent of impact of metabolic syndrome that can 
be measured using MR. (Magnetic Resonance Imaging 





AIM OF THIS THESIS
The aim of this thesis is to further develop advanced body MR techniques to gain more 
insight in the metabolic syndrome (MetS). This was realized by optimizing MR imaging and 
spectroscopy measurements in the body, as well as ex-vivo. One of the optimization steps 
includes development of high dielectric materials to increase sensitivity of the body MR 
measurements.
OUTLINE OF THIS THESIS
In Chapter one a general introduction is given to body MR and the challenges of high field 
body MR are discussed. Basic background information for dielectric pads is given, which 
can be applied to address a major challenge of high field body MR. Moreover some basic 
principles of MR spectroscopy are explained. Furthermore, the metabolic syndrome and 
the use of high field body MR to evaluate this syndrome are described. In the first part of 
this thesis we aimed to develop new techniques for high field body MR which are 
described in chapters two, three, and four. Chapter two (Increasing Signal Homogeneity 
and Image Quality in Abdominal Imaging at 3 T with Very High Permittivity Materials) 
examines whether inhomogeneous transmit fields (a major challenge in high field body 
MR), can be improved by passive shimming. High dielectric materials were designed, 
simulated and tested for liver imaging to increase image quality. Chapter three (Improved 
Cardiac Proton Magnetic Resonance Spectroscopy at 3 T Using High Permittivity Pads) 
demonstrates how a similar passive shimming approach can be applied in cardiac 
spectroscopy to increase the SNR of the spectra. In Chapter four (Parameter Optimization 
for Reproducible Cardiac 1H-MR Spectroscopy at 3 Tesla) we investigated how cardiac 
proton MR spectroscopy measurements can be optimized for high field and reports 
results on reproducibility. In the second part of this thesis, consisting of chapters five, six 
and seven, the techniques described in chapters 2, 3 and 4 are applied in clinical studies 
in order to gain additional insight in the development/treatment of the Metabolic Syn-
drome (MetS). In Chapter five (MR of Multi-Organ Involvement in the Metabolic Syndrome) 
a review is presented on multi-organ involvement in the metabolic syndrome and how this 
can be evaluated using magnetic resonance techniques. Chapter six (Metabolic Imaging 
of Human Kidney Triglyceride Content: Reproducibility of Proton Magnetic Resonance 
Spectroscopy) reports the results of a feasibility study of in-vivo renal proton MR spec-
troscopy and describes the reproducibility of this measurement. Chapter seven (Imaging 
Fatty Kidney by Clinical Proton Magnetic Resonance Spectroscopy (1H-MRS): a First 
Validation and Dietary Intervention Study using Porcine Kidneys) validates renal proton 
MR spectroscopy in comparison to biopsies in porcine kidneys. Furthermore, the effects 
of dietary intervention on renal lipids are assessed. In Chapter eight all chapters are 
summarized and discussed. 
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The appearance of severe signal drop-outs in abdominal imaging at 3 T arises primarily 
from areas of very low B1
+ transmit field in the body, and is problematic in both obese as 
well as very thin subjects. In this study, we show how thin patient-friendly pads containing 
new high permittivity materials can be designed and optimized, and when placed around 
the subject increase substantially the B1
+ uniformity and the image quality. Results from 
nine healthy volunteers show that inclusion of these dielectric pads results in statistically 
significant decreases in the coefficient of variance of the B1
+ field, with stronger and more 
uniform fields being produced. In addition there are statistically significant decreases in 
timeaveraged power required for scanning. These differences are present in both 
quadrature-mode operation (coefficient of variance decrease, P  0.0001, mean 25.4 ± 
10%: power decrease, P = 0.005, mean 14 ± 14%) and also for the RF shimmed case 
(coefficient of variance decrease, P = 0.01, mean 16 ± 13%: power decrease, P = 0.005, 
mean 22 ± 11%) of a dual-transmit system.
INCREASING SIGNAL HOMOGENEITY AND IMAGE QUALITY IN 
ABDOMINAL IMAGING AT 3 T WITH VERY HIGH PERMITTIVITY 
MATERIALS
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INTRODUCTION
The appearance of signal voids in abdominal MRI in both volunteers and patients at 3 T 
has been noted by many researchers.1–6 Some report that severely obese patients present 
the worst situation,2 others that this effect also occurs for very thin patients.1,3 As noted by 
Bernstein 1 ‘‘Image shading and uneven contrast resulting from spatial variation in the 
transmit B1
+ field remains one of the biggest unsolved problems for routine clinical 3 T 
imaging today.’’ The phenomenon of signal loss is often referred to as ‘‘dielectric reso-
nance.’’ Pregnant women and patients with ascites are universally problematic, and 
subsequently are almost always studied at 1.5 T.5,6 The clinical, and implicitly financial, 
importance of this situation is emphasized by the recent commercial introduction of 
dual-transmit RF systems at 3 T, in which the quadrature body coil is effectively split into 
two linear coils, each of which can be driven with an independently controlled magnitude 
and phase. The two degrees of freedom (relative amplitudes and relative phases of the 
two channels) compared to only one (absolute amplitude) for a conventional single 
transmit system can produce considerable increases in RF transmit homogeneity,7,8 as 
has long been known theoretically and investigated extensively for imaging at 7 T.9–11 
However, experience at our institution and elsewhere indicates that, despite improved 
performance, dual-channel 3 T systems do not consistently solve the problem of image 
inhomogeneities. Experimental and simulation work has suggested that there are still 
further improvements using an eight channel transmit body coil,12,13 but such a setup is 
not currently commercially available.
A second approach to address the issues of RF inhomogeneity in 3 T abdominal imaging is 
the use of ‘‘dielectric pads’’.14–17 Previous very simple pads typically are made from 
ultrasound gel with dissolved paramagnetics such as manganese chloride to give a short 
T2 and hence low background MR signal. Some institutions report that these are used 
locally for most abdominal scans,15 whereas others report that they are not commonly 
used in the wider community.1 There are several problems with this approach as currently 
implemented. From a practical point-of-view the pad is 3 cm thick and therefore some-
what patient-unfriendly. In the usual implementation, a single pad is placed centrally on 
top of the patient irrespective of the patient size: the large thickness makes it impractical 
to place a second one underneath the patient to improve the transmit field in the posterior 
regions. Perhaps most importantly, no optimization of the properties (size, shape, 
thickness, placement, or relative permittivity) of the dielectric pad or material has been 
shown.
In this article, we present both electromagnetic (EM) simulations and experimental data 
using thin pads with high permittivity materials based upon aqueous suspensions of 
metal titanates which have a relative permittivity of 300.18,19 Placement of two of these thin 
(1 cm) pads anterior and posterior to the subject is shown to improve significantly both the 
transmit field homogeneity and the overall image quality. The imaging performance both 
with and without dielectric pads is compared experimentally to that of a dual-channel RF 
system in quadrature mode, as well as the combined approach using both the dielectric 
pads and RF shimming. Significant improvements in homogeneity due to the pads are 
found when the scanner is used in the conventional quadrature mode, and the best 






A commercial package based on a finite difference time domain method (xFDTD, Rem-
com, PA) was used for all simulations. The RF coil was modeled as a 16 rung high pass 
birdcage coil with a diameter of 61 cm, length 56 cm, driven in quadrature mode by 32 
ideal current sources with an impedance of 50 V. This corresponds to a dual transmit 
system being operated in the conventional quadrature or fixed phase mode, in which the 
phase relationship between the two channels is fixed at 90°. One male (Duke, body mass 
index 23) or one female (Ella, body mass index 22) model from the virtual family was 
placed in the center of the coil.20 An isotropic grid cell size of 2.5 mm was used with a 
seven-layer perfectly matched absorbing boundary. A sinusoidal current was applied at 
128 MHz, with a timestep of 4.8 ps. A criterion of -50 dB was set for convergence of the 
steady-state fields, and typical simulation times were 30 min using a graphics processing 
unit. The transmit magnetic field (B1
+ ), electric (E) field, and specific absorption rate (SAR) 
were simulated for each configuration: normalization was to 1 W dissipated power.
To determine the optimal pad permittivity, a grid search was used in which the relative 
permittivity values of two pads (one anterior, one posterior), each of thickness 1 cm, were 
varied from 1 to 650 in steps of 50. For comparison, a 3 cm thick commercially available 
water pad was included in the simulations.14,15 The coefficient of variation (Cv) of the B1
+ 
field, i.e., 100 multiplied by the standard deviation of the B1
+ divided by its mean value, 
across the simulated B1
+ map (transverse orientation) was evaluated in MATLAB (Math-
works, Natick, MA). In the transverse slices, the value of Cv is calculated throughout the 
entire cross-section (not considering the arms). For coronal slices, a rectangular region 
of interest is assigned through the thorax and abdominal region of the body.
Production of High Permittivity Pads
High permittivity pads were produced based on the approach described previously.19 
Briefly, barium titanate (BaTiO3) powder (Alfa Aesar GmbH) was mixed with water until a 
saturated suspension was reached since the aim was to produce as high a permittivity as 
possible. Approximately, a 4:1 weight/weight ratio of barium titanate powder to water was 
used. The dielectric constant was measured using a dielectric probe kit (85070E, Agilent 
Technologies, Santa Clara, CA) and a network analyzer, and had a value of 300. This is 
substantially higher than reported in a previous publication,19 and emphasizes the fact 
that the permittivity that can be reached is critically dependent upon the surface proper-
ties and size of the barium titanate powder used. Two pads, each 1 cm thick, of the 
suspension were heat-sealed within polypropylene pads, with dimensions 28 x 22 cm2 
(left/right and head/foot dimensions, respectively). The weight of these pads was approxi-
mately 2 kg, significantly less both in thickness and weight compared to a commercial 
water-based pad (3 cm thick and 3.2 kg weight).
MRI Protocols
All experiments were approved by the Leiden University Medical Center Committee for 
Medical Ethics, and performed on a dual-transmit 3 T Philips Achieva. Nine volunteers 
(seven male, two female), with ages between 25 and 50, and body mass indices (BMIs) 
between 18 and 38, were imaged. The transmit coil was the inbuilt body resonator, and a 
six-element ‘‘cardiac array’’ was used for signal reception: this consisted of three 
elements anterior and three elements posterior to the patient. All experiments were 
performed first with the pads in place, the pads were then removed with as little subject 
motion as possible, and rescanning without the pads was performed. Figure 1 shows a 
schematic of the EM simulation setup accompanied by a photograph of the positioning of 
the thin pad on the anterior side of the volunteer. The transmit field of the body coil was 
mapped using the method of Yarnykh at 2.5 mm isotropic resolution with a target angle of 
45° to avoid ambiguity for any actual tip angle close to or greater than 90°.21 Imaging 
parameters: three-dimensional gradient echo sequence: echo time = 20 ms, TR1 = 100 
ms, TR2 = 250 ms, nominal flip angle 50°, 64 x 64 data matrix, transverse slice thickness 
10 mm, 1 mm slice gap, field-of-view ~ 250 x 450 x 120 mm3 with slight variations depen-
dent upon subject size. Tip angle maps were generated from the ratio of the signal 
intensities obtained with the two different pulse repetition time values. Tip angle maps 
were then converted to transmit sensitivity (B1
+ per square root of power) for direct 
comparison with EM simulations. Coefficient of variation values were calculated as 
described in the previous section. For assessment of image quality, T1-weighted turbo 
gradient echo sequences were run with the following parameters: echo time = 2.3 ms, 
pulse repetition time = 10 ms, tip angle = 15°, 252 x 149 data matrix, slice thickness = 7 
mm, 1 mm slice gap, field-of-view = 297 x 375 x 77 mm3, acquisition time = 13.5 s for six 
slices, linear phase encoding, scan percentage 75%, turbo echo factor 149, no flow 
compensation. Images were acquired during breathhold (exhalation).
Four different settings were used to investigate the separate effects of RF shimming and 
the dielectric pads. First, RF shimming was turned off forcing the conventional quadra-
ture relationship between the two separate transmit channels. Second, RF shimming was 
enabled, in which a rapid grid search is performed by the Philips system with a free range 
of relative amplitudes and phase difference between the two channels. RF shimming was 
performed separately for the cases with and without the dielectric pads in place.
Measurements of the time-averaged power during the imaging sequence are recorded in 
the log file of the scanner. These measurements are performed directly at the amplifier, 
and measure both the forward and reflected powers, the difference between the two 
being the power delivered to the system (losses in cables and connectors between the RF 
amplifiers and the RF coil may be up to 15%, but this percentage does not vary signifi-
cantly with absolute power).
FIGURE 1. (left) Schematic of the setup for the EM simula-
tions with a dielectric pad (red) with thickness 1 cm placed 
on the abdomen. An identically shaped pad (green) is 
placed on the back, in the same position. (right) photo-
graph of a volunteer with the pads in place. [Color figure 






Statistical analysis was performed using Graphpad Prism (La Jolla, CA). Paired two-sided 
Student’s t-tests were performed for conditions of with/without dielectric pads for data 
acquired with and without the dielectric pads.
RESULTS
EM Simulations
Figure 2 shows simulation results of the B1
+ field in the male Duke model. The grid search 
gave an optimum configuration with relative permittivities of 400 for the anterior pad and 
500 for the posterior pad for a pad thickness of 1 cm. In practice, the highest permittivity 
that could be achieved was 300 using essentially a saturated suspension of barium 
titanate powder in water. 
In Figure 2, the values of Cv are given for the situations of no pads, the commercial pad (3 
cm thick, water-based, εr = 80), the optimum configuration of the two pads placed anterior 
and posterior, and the practical configuration of two pads with relative permittivities of 
300. As outlined in the methods section, in the transverse slice, the value of Cv is calcu-
lated throughout the entire cross-section (not considering the arms), and for the coronal 
slice through the thorax and abdominal region of the body. There are considerable 
improvements in the B1
+ homogeneity for the anterior/posterior high permittivity pads 
compared to both the situation with no pads, and also the asymmetric placement of the 
commercial pad on only the anterior side of the subject. It should be noted that, since 
optimization was performed on the transverse slice due to the much more defined 
region-of-interest (essentially the entire slice without the arms), the value of Cv in the 
coronal plane can actually be slightly lower for the εr = 300 case than the ‘‘optimum’’ 
permittivity value.
Figure 3 shows corresponding plots for the female Ella model. In this case, the optimum 
configuration was found to correspond to relative permittivities of 300 for the front and 
back. The dependence of the value of Cv on the permittivities of the two pads for both the 
Duke and Ella model is shown in Figure 4. As can be seen, there is a relatively smooth 
minimum for values around 300 – 500, but the increase is quite severe for values below 
about 300 or above 500. These results confirm the simulation results in Figure 2 which 
demonstrate that there is a very small increase in Cv when operating with pads with 
permittivity of 300 compared to the optimum values of 400/500.
FIGURE 2. EM simulations of the B1
+ field in the ‘‘Duke’’ 
model. (a)–(d) transverse slice through the centre of the 
liver, (e)–(h) corresponding coronal slices. (a) and (e) no 
dielectric pads, (b) and (f) a 3 cm thick ‘‘commercial’’ 
water-based pad, (c) and (g) the optimum solution for two 1 
cm thick pads with εr = 400 for the anterior pad and εr = 500 
for the posterior pad, (d) and (h) the practically realizable 
situation with two 1 cm pads each with εr = 300. The coeffi-
cient of variation is shown for each configuration.
FIGURE 3. EM simulations of the B1
+ field in the ‘‘Ella’’ 
model. (a)–(c) transverse slice through the centre of the 
liver, (d)–(f) corresponding coronal slices. (a) and (d) no 
dielectric pads, (b) and (e) a 3 cm thick ‘‘commercial’’ 
water-based pad, (c) and (f) the optimum solution for two 1 
cm thick pads each with εr = 300. The coefficient of varia-
tion is shown for each configuration.
FIGURE 4. Plots of the coefficient of variation (vertical axis) 
versus the permittivities of both the anterior and posterior 
pads. (left) Duke and (right) Ella models. 





To determine whether the high permittivity pads increase either the local or global SAR 
values, Figure 5 shows transverse and coronal plots of the local (1 g tissue average) SAR 
values for the Duke model generated by the quadrature-driven body coil. The highest 
values are generally found in the arms (since they are in the region of the highest electric 
field of the RF coil), and all values in the body are at least a factor-of-two lower. There are 
negligible differences introduced by either the commercial or new high permittivity pads. 
Very similar results were found for Ella (data not shown). These results correspond to the 
conventional quadrature-driven body coil, but it is anticipated that similar effects occur in 
the RF-shimmed case.
Experimental Results
Figure 6 shows transverse slices acquired for five of the nine volunteers (for clarity) for 
all four configurations of with/without RF shimming and with/without high permittivity 
pads. Clear improvements in image homogeneity are evident with the addition of the pads.
Figure 7 demonstrated the B1
+ maps acquired without and with the dielectric pads in place 
for the same volunteers and the same conditions as shown in Figure 6. There is good 
agreement with the simulated results presented in Figure 2.
FIGURE 5. EM simulations of the 1-g averaged SAR in the 
‘‘Duke’’ model. a–d: transverse slice through the centre of 
the liver, (e)–(h) corresponding coronal slices. (a) and (e) 
no dielectric pads, (b) and (f) a 3 cm thick ‘‘commercial’’ 
water-based pad, (c) and (g) the optimum solution for two 1 
cm thick pads with εr = 400 for the anterior pad and εr = 500 
for the posterior pad, (d) and (h) the practically realizable 
situation with two 1 cm pads each with εr = 300. [Color 
figure can be viewed in the online issue, which is available 
at wileyonlinelibrary.com.]
FIGURE 6. Comparison of T1-weighted turbo-spin echo 
images acquired from five volunteers with BMI values 
between 18 and 24 for four different configurations of 





Figure 8 shows a plot of the Cv for all nine volunteers for the four different imaging 
conditions. For the quadrature drive, the Cv decreased in all cases, and often by a sub-
stantial amount (mean 25.4 ± 10%), with the addition of the dielectric pads. In the RF 
shimmed case, a decrease (mean 16 ± 13%) in Cv for all but one case was achieved using 
the pads. Statistical analysis showed a significant decrease (P  0.0001) in Cv between 
quadrature mode without and with the dielectric pads, and also in the RF shimmed case 
without and with the pads (P = 0.005).
FIGURE 7. Measured B1+ maps from the same volunteers as 
in Fig. 6 for the same four configurations. [Color figure can 
be viewed in the online issue, which is available at wileyon-
linelibrary.com.]
FIGURE 8. Plot of coefficient of variation for 
all nine volunteers. Statistically significant 
decreases are shown for both quadrature 
driven and RF-shimmed cases when 
introducing the dielectric pads.
In terms of the RF power required for image acquisition, there were also statistically 
significant reductions in both the peak power and time-averaged power using the dielec-
tric pads. As with most power optimization algorithms on commercial systems, the 
average flip angle across the central transverse slice is calibrated. In the case of an 
inhomogeneous B1
+ distribution, this causes overtipping in areas of high transmit effi-
ciency, and undertipping in areas of low efficiency.
Figure 9 shows the time-averaged power needed for the T1-weighted turbo gradient echo 
sequence used to produce the images in Figure 6: these powers were read from the log 
file that was stored on the scanner, with the powers being measured at the output of the 
RF amplifier as described in the methods section. The power demands were in all but one 
case lower with pads than without pads. Statistical analysis showed a significant decrease 
in average power when the high permittivity pads were in place for both the quadrature-
driven mode (P = 0.01) and RF shimmed mode (P = 0.0004).
FIGURE 9. Plot of time averaged power 
measured for the images acquired in Fig. 6 
for all nine volunteers. Statistically signifi-
cant decreases are shown for both quadra-
ture-driven and RF-shimmed cases when 





The intrinsic inhomogeneity introduced by imaging an elliptical object with a quadrature 
RF coil is well known,22 and different patient geometries may mitigate or exacerbate this 
effect. The recent commercial introduction of dual-transmit systems has shown substan-
tial improvement in image quality, but does not yet represent a complete solution to the 
problem. The ‘‘ability’’ of high permittivity materials 23 to increase the homogeneity of the 
transmit magnetic field has been shown primarily for neuroimaging at high field either 
with water bags 24 or materials formed from metal titanates.18,19,25 Recently, improvements 
for neuroimaging at 3 T have also been reported using large water pads.26 The lower the 
magnetic field, the higher the permittivity must be to compensate for B1 inhomogeneities 
since displacement currents are proportional to the operating frequency. In neuroimaging 
at 7 T, the optimum value of the permittivity was found to be 100.20 In this current work, we 
have demonstrated that statistically significant improvements in transmit efficiency for 
abdominal imaging at 3 T can be achieved using thin, high permittivity pads placed 
anterior and posterior to the subject. There are large measured improvements when 
operating the system in quadrature mode, which corresponds to the vast majority of 
single channel 3 T systems currently available in the world. Even when operating in dual 
transmit mode with RF shimming on a state-of-the-art multichannel system, the dielec-
tric pads provided a statistically significant increases in image homogeneity, as well as a 
reduction in the total power absorbed by the body.
The geometry which we studied is relatively simple, consisting only of two pads of 1 cm 
thickness, and certainly it can be anticipated that further improvements may result from 
optimized geometries including more pads in a more complex geometry. Another refine-
ment would be to optimize the coefficient of variance over the entire three-dimensional 
imaging volume, rather than just a central slice as in this work. Higher permittivity 
materials should bring further increases in image quality, as well as reduction in the 
thickness of the required pads, particularly in the case of patients with higher body mass 
index values than in healthy volunteers studied here. The current study does not have 
enough volunteers, or volunteers with sufficient range of BMI values, to be able to relate 
directly the improvements afforded by the dielectric pads to the BMI, or probably even 
more relevant to the geometry of the body. Future clinical studies including patients with 
much higher BMI will be required to establish such a relationship. In this work no 
increases in global SAR (assuming body loss dominance) were evident, and indeed a 
reduction in local SAR was simulated for the quadrature-driven body coil. This was 
experimentally demonstrated by measuring substantial reductions in average power 
levels on the MR system both for the quadrature-driven mode, and also the RF shimmed 
mode.
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The aim of this study was to determine whether high permittivity (HP) pads can be used to 
increase the signal-to-noise ratio (SNR) of cardiac proton magnetic resonance spectros-
copy at 3 T, allowing faster data acquisition.
Materials and Methods:
The institutional review board approved the study protocol, and written informed consent 
was obtained from all participants. In 22 healthy volunteers, water-suppressed localized 
spectra were acquired in the interventricular septum without and with HP pads. The SNR 
and myocardial triglyceride content (MTGC) were measured without and with the HP pads, 
and the results were compared with a paired sample Student t test.
Results:
Application of HP pads increased mean (SD) SNR from 27.9 (15.6) to 42.3 (24.4) (P  0.0001), 
a mean gain of 60%. The acquisition time can thereby be reduced from just under 5 
minutes to just under 2 minutes while maintaining the same SNR. The mean (SD) MTGC 
was 0.39% (0.17%) without pads and 0.38% (0.15%) with pads (P = 0.83) for the healthy 
volunteers, showing that no bias is introduced by using the pads. No difference in spectral 
linewidth was measured (P = 0.80), the values being 17.4 (4.9) Hz without and 17.1 (3.2) Hz 
with pads. Both transmit and receive maps showed increases in sensitivity due to the 
presence of the HP pads.
Conclusions:
High permittivity pads improve cardiac proton magnetic resonance spectroscopy at 3 T by 
increasing the SNR on average by 60%, which can be used to reduce data acquisition time 
significantly, allowing fast assessment of MTGC without compromising spectral quality. 
The SNR increase arises primarily from the increase in receive sensitivity of the phased 
array, which is more closely coupled to the body via the HP pads. In addition, the transmit 
efficiency is also increased, allowing shorter or lower power radiofrequency pulses.
IMPROVED CARDIAC PROTON MAGNETIC RESONANCE SPECTROSCOPY 
AT 3 T USING HIGH PERMITTIVITY PADS
Adapted from Investigative Radiology. 2016 Feb;51(2):134-8.
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INTRODUCTION
Myocardial triglyceride content (MTGC) reflects the process of ectopic intracellular fat 
accumulation, which is linked to the development of heart failure.1 This process is called 
steatosis and has proved to be an important parameter in the field of cardiovascular 
disease related to obesity, metabolic syndrome, and type 2 diabetes mellitus.2–8 Myocar-
dial steatosis can be reversed using therapeutic procedures, a fact which emphasizes the 
importance of a reliable measurement technique to monitor the cardiac MTGC. The 
criterion standard for the quantification of cardiac MTGC is proton magnetic resonance 
spectroscopy (1H-MRS). However, cardiac 1H-MRS is challenging due to an intrinsic low 
signal-to-noise ratio (SNR) as well as static and dynamic fluctuations in both the main 
magnetic field (B0) as well as in the transmit field (B1
+). To increase the SNR, many signal 
averages must be coadded, often between 32 and 128 averages at a field strength of 1.5 T. 
This will result in long acquisition times, more than 10 minutes, limiting the use of cardiac 
1H-MRS in a practical clinical protocol in which many other types of scan must also be 
acquired. Another method to increase SNR is to acquire data at a higher field strength.9 
However, cardiac 1H-MRS at 3 T is even more challenging than at 1.5 T due to increases in 
the degree of static and dynamic B0 and B1
+ inhomogeneities. Dynamic B0 fluctuations, 
caused mainly by respiratory motion, result in phase and frequency variations between 
consecutive signal averages, thereby decreasing signal intensity and increasing linew-
idths (as well as changing line shape from Gaussian to Voigt) and complicating MTGC 
quantification. Dynamic B1
+ inhomogeneities, caused also by respiratory motion, result in 
fluctuations in signal intensity per signal average.
Recent work has shown that it is possible to increase the quality of 3 T cardiac imaging, 
simultaneously increasing B1
+ homogeneity over the volume of interest (VOI) and decreas-
ing the required power, using high permittivity (HP) pads.10 Therefore, the purpose of this 
study was to determine whether the application of HP pads can increase the SNR in 
cardiac 1H-MRS at 3 T, allowing shorter data acquisition times.
MATERIALS AND METHODS
Participants
The institutional review board approved the study protocol, and written informed consent 
was obtained from all participants. The study was conducted according to the principles 
expressed in the Declaration of Helsinki. Twenty-two healthy volunteers underwent 
cardiac 1H-MRS from December 2013 until February 2014. Because of a voxel placement 
error (contamination with pericardial lipid), 2 volunteers were excluded from further 
analysis. The remaining 20 volunteers consisted of 12 female and 8 male subjects with a 
mean (SD) age of 29 (11) years (range, 19–53 years) and with a mean (SD) body mass index 
of 23 (3) kg/m2 (range, 19.7–34.1 kg/m2).
Data Acquisition
Experiments were performed on a 3 T Ingenia whole-body magnetic resonance imaging 
scanner (Philips Healthcare, Best, the Netherlands) with dual-channel transmit capabil-
ity. The body coil was used for transmission and an anterior (16 elements) and posterior 
(12 elements) array for reception. The entire scan protocol was performed twice: once 
without the HP pads and once with the HP pads placed between the patient and the 
receive array on the anterior and posterior sides of the thorax. To reduce any potential 




were acquired with a random choice of which configuration was used first. Proper 
placement of the pads was confirmed by a 30-second survey scan. A series of scout scans 
was performed to localize the MRS voxel, 15 mL (40 x 15 x 25 mm3), within the myocardial 
interventricular septum (Figure 1A). Point resolved spectroscopy spectra were acquired 
with an echo time of 35 milliseconds without water suppression (repetition time: 9 
seconds, 16 averages) and with selective excitation water suppression (repetition time: 
3.5 seconds, 12–48 averages).11 The unsuppressed spectrum was used as a reference for 
triglyceride quantification. Before each scan radiofrequency (RF) pulse power optimiza-
tion, pencil beam B0 shimming and resonance frequency determination were performed 
using 5 breath-holds (exhalation). All spectral acquisitions were respiratory navigator 
gated.12 With a mean (SD) navigator efficiency of 57% (10%), this resulted in a mean 
acquisition time of 4 minutes and 55 seconds for the water-suppressed spectra (48 
averages). The preparation time was on average 1 minute and 56 seconds, and the 
acquisition of the reference signal was 4 minutes and 15 seconds, resulting in a mean 
total scan time of 11 minutes and 6 seconds. Individual signal averages were saved 
separately for subsequent data processing. The navigator axis was placed along the 
lung-liver interface. Measurements were performed to determine the most stable 
cardiac phase for the electrocardiographical triggering delay and resulted in a post 
R-wave delay of 200 to 250 milliseconds, depending on the heart rate, which agrees with 
results from previous authors.13 For 11 volunteers, transmit field (B1
+) maps were meas-
ured based on the saturated double-angle method.14 Reception sensitivity (B1
-) maps were 
calculated in 4 volunteers. This was done by acquiring electrocardiography- triggered 
3-dimensional (3D) gradient-echo sequence with a flip angle of 5 degrees, geometrically 
aligned with the B1
+ map. The resulting image is proportional to the product of the receive 
sensitivity and the B1
+, as described by Wang et al.15 The receive sensitivity is then calcu-
lated by dividing the 3D gradient-echo image by the B1
+.
Preparation of HP Pads
The HP pads were constructed using an aqueous (H2O) suspension of barium titanate with 
a 4:1 mass-mass ratio.10 This results in a very dense mixture with a relative permittivity of 
approximately 300. Two HP pads, one 2 cm thick (placed anterior) and the other 1 cm thick 
(placed posterior), with a dimension of 20 x 20 cm2 were respectively centered above and 
below the location of the spectroscopy VOI in both the feet-head and left-right direction 
(Figure 1B). The weights of these HP pads were 2.3 kg and 1.3 kg, respectively.
Data Processing
The spectra were fitted in the time domain to a Gaussian line shape using the advanced 
method for accurate, robust, and efficient spectral fitting algorithm in Java-Based 
Magnetic Resonance User Interface (jMRUI v5.0; MRUI Project).16 As prior knowledge, the 
linewidth of the CH3 resonance was set to be equal to that of the (CH2)
n groups, and the 
frequency of the CH3 peak was fixed at −0.4 ppm with respect to the frequency of the 
(CH2)
n peak. The SNR is defined as the summed amplitude of the spectral component of 
the triglyceride-methyl (CH3) and the triglyceride-methylene (CH2)
n peaks divided by the 
SD of the noise. The noise was taken from the last 100 data points of the time-domain free 
induction decay, which was confirmed to be signal free. The total MTGC was calculated 
using the following equation;
The SNR for reduced scan times was calculated for 48 to 36, 24, and 12 averages, reduc-
ing the mean acquisition times from 5 to 3.75, 2.5, and 1.25 minutes, respectively, to study 
the effect of scan time on SNR without and with pads. To test the effect of the HP pads on 
the linewidth, the full width at half maximum of the water peak was measured in all 
volunteers. The average transmit power values from the RF amplifier were read from the 
log file produced by the scanner.
Statistical Analysis
All statistical analyses were performed by using statistical software IBM SPSS Statistics 
(version 20, IBM, Chicago, IL). Numerical data were reported as mean (SD). A paired 
samples Student t test was performed to compare SNR, spectral linewidths, fat fraction, 
and RF transmit power without and with the HP pads. Data were considered statistically 
significant at P values less than 0.05.
FIGURE 1. A, Placement of the spectroscopy voxel (red box) 
in the interventricular septum on the 4-chamber and short 
axis view. B, Placement of the HP pads shown on the 
transverse and sagittal survey scan. Both the anterior and 
posterior HP pads were centered on the location of the 
spectroscopy VOI in both the feet-head and left-right direc-
tion. Figure 1 can be viewed online in color at www.investi-
gativeradiology.com.
Data Processing
The spectra were fitted in the time domain to a Gaussian line shape using the advanced 
metho f r accu ate, robust, a d efficient spe tral fitting algorithm in Java-Based Magnetic 
Resonance User Interface (jMRUI v5.0; MRUI Project).16 As prior knowledge, the linewidth of 
the CH3 resonance was set to be equal to that of the (CH2)n groups, and the frequency of the 
CH3 peak was fixed at −0.4 ppm with respect to the frequency of the (CH2)n peak. The SNR 
is defined as the summed amplitude of the spectral component of the triglyceride-methyl 
(CH3) and the triglyceride-methyl ne (CH2)n eaks divided by the SD of the n ise. The noise 
was taken from th  last 100 data points of the time-domain free i duction decay, which was 
confirmed to be signal free. The total MTGC was calculated using the following equation;
MTGC =
triglyceride methyl (CH3) + triglyceride methylene (CH2)n
water +  triglyceride methyl (CH3) + triglyceride methylene (CH2)n
× 100%  (Equation 1)
The SNR for reduced scan times was calculated for 48 to 36, 24, and 12 averages, reducing 
the mean acquisition times from 5 to 3.75, 2.5, and 1.25 minutes, respectively, to study the 
effect of scan time on SNR without and with pads. To test the effect of the HP pads on the 
linewidth, the full width at half maximum of the water peak was measured in all volunteers. 
The average transmit pow r values from the RF amplifier were read from the log file 
produced by the scanner.
Statistical Analysis
All statistical analyses were performed by using statistical software IBM SPSS Statistics 
(version 20, IBM, Chicago, IL). Numerical data were reported as mean (SD). A paired 
samples Student t test was performed to compare SNR, spectral linewidths, fat fraction, and 
RF transmit power without and with the HP pads. Data were considered statistically 






Three different spectra from a single volunteer are shown in Figure 2. The SNR is 
increased by 90% for this volunteer by applying the HP pads, as shown by comparing the 
middle and left spectra. A comparison of the middle and right spectra shows that the 
same spectral SNR can be achieved using the pads with 60% fewer signal averages.
In Figure 3, the MTG SNR is plotted for each volunteer without and with HP pads. The 
mean (SD) SNR increased from 27.9 (15.6) to 42.3 (24.4) (P  0.0001), and the SNR change 
ranged from −4.0 to +44.0 with an average increase of 14.2. The mean gain in SNR by 
using the HP pads is 60%. Measurements of the noise showed a significant increase with 
the pads in place (3.36e-6 [8.04] without, 4.06e-6 [9] and with pads), implying a closer 
coupling to the region of interest, resulting in an overall increase in SNR.
In Figure 4, the SNR of the MTG signal as a function of the acquisition time is shown for a 
single volunteer. It can be seen that significant reductions in time, for this volunteer from 
5 minutes to a just over 2 minutes (similar to the data shown in Figure 2), can be achieved 
by using the HP pads while maintaining the same SNR equal compared with the scan 
without the HP pads.
FIGURE 2. Three water-suppressed spectra of a single 
volunteer. The spectrum on the left was acquired with the 
HP pads, and the spectrum in the center was acquired 
without the pads in place. The spectrum on the right is 
identical to the left spectrum(with HP pads) but has been 
reconstructed with only the first 19 averages of the total 48 
averages. Multiple triglyceride resonances [CH3 at 0.9 
ppm, (CH2)
n at 1.3 ppm, CH2CH2COO marked with number 2 
at 1.5 ppm, CH2CH = CHCH2 and CH2COO marked with 
number 1 around 2.1 ppm], a creatine methyl resonance at 
3.0 ppm, and a trimethylammonium resonance at 3.2 ppm 
can be distinguished in the spectrum.
FIGURE 3. Myocardial triglyceride SNR 
for all 20 volunteers without and with 
the HP pads (48 averages).
FIGURE 4. Signal-to-noise ratio of the MTG signal against 
acquisition time, acquired in the same volunteer as shown 
in Figure 2, without and with the HP pads. The horizontal 
dotted line is the SNR level of the total acquisition (5 
minutes) without the HP pads. This plot shows the SNR of 
the full scan without pads is reached in just over 2 minutes 
when using the HP pads effectively cutting acquisition time 






There was no significant difference (P = 0.80) in the linewidths without and with the HP 
pads, the values being 17.4 (4.9) Hz and 17.1 (3.2) Hz, respectively.
Transmit and Receive Sensitivities
The peak B1
+ available on the scanner is 13.5 μT. Without the HP pads, the transmit field 
strength in the VOI was 11.2 (1.4) μT, whereas with the pads, a transmit field of 12.5 (1.3) μT 
was reached (P = 0.0001). This translates to an average increase in B1
+ of 12% in the VOI. 
The average required power for the scan was 20.9 W without the HP pads and 17.1 W with 
the HP pads (P  0.0001). The receive sensitivity (B1
-) increased from 326 (50) without the 
HP pads to 424 (45) with the HP pads. This translates to an average increase in B1
- of 30% 
in the VOI. Figure 5A shows transmit (B1
+) fields per square root of input power in a single 
volunteer without and with the HP pads. The field is plotted along the long axis of the 
selected volume shown in Figure 1. Figure 5B shows the corresponding B1
+ field achieved 
with the slice-selective power optimization on the scanner, and Figure 5C shows the 
calculated receive sensitivity (B1
-) maps.
Myocardial Triglyceride Content
The MTGC was calculated to be 0.39% (0.17%) without the HP pads and 0.38% (0.15%) with 
the HP pads (P = 0.83).
FIGURE 5. A, The transmit efficiency is shown in the left 
panel for a single volunteer with and without pads. On the 
right the transmit efficiency is plotted along the voxel of 
interest. B, On the left the B1
+ maps are shown for a single 
volunteer without and with the HP pads. The gain in SNR 
was 40% for this volunteer. The maximum transmit field 
from the body coil is set at 13.5 µT. On the right, the B1
+ 
intensity is plotted at the location of the spectroscopy voxel 
that is noted as a white line from anterior to posterior in 
the B1
+ maps. C, The left panel shows B1
- maps of a single 
volunteer without and with the HP pads placed. The gain in 
SNR was 110% for this volunteer. In the right panel, B1
- 
intensity is plotted at the location of the voxel of interest 
that is noted as a white line from anterior to posterior in 
the B1
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DISCUSSION
The main finding of this study is that the HP pads significantly increase the SNR of cardiac 
1H-MRS at 3 T. The increased SNR can be exploited to reduce the number of required 
signal averages, reducing the mean acquisition time by 60%. The acquisition time for our 
standard MRS protocol can in this way be reduced from 5 minutes to only 2 minutes for 
the same spectral quality. These results are in line with a previous study on the effects of 
HP pads on cardiac imaging,10 although in that particular study quantitative analysis was 
performed across the entire cardiac volume, rather than the much smaller section of the 
myocardial wall from which spectra were acquired in this study. The authors found 
significant increases in receive sensitivity close to the anterior section of the heart, with 
Figure 5 displaying an approximately 30% increase in receive sensitivity, very similar to 
that quantitatively determined in this current study. 
Our results show that the main factor responsible for the increased SNR is the 30% 
increase in receive sensitivity due to an increased coupling between the coil array and the 
body by using the HP pads. The transmit field increased by 12% on average accompanied 
by an 18% decrease in average power resulting in a significantly increased transmit 
efficiency. This effect was also seen in a previous study, which considered the effects of 
the HP pads in cardiac imaging.10 No significant differences in spectral linewidth were 
measured using the HP pads, which can be explained by the large distance between HP 
pads and the VOI. From the SNR results for all volunteers, it was noted that, in 2 of the 
total 20 volunteers, adding the pads decreased the SNR. This did not seem to be related to 
body size or sex and is most likely related to faulty placement of the pads. We also 
observed a large variance in spectral SNR between the different volunteers. This variance 
did not seem to be correlated with body mass index but more likely to the chest size and 
subcutaneous fat levels. Although volunteers noted the extra weight of the HP pad in 
addition to that of the receive array on their chest, they did not rate this as uncomfortable. 
The effect on the SAR of the HP pads has been described previously in the study by Brink 
and Webb10 (Figure 3). They showed that the local increase in transmit efficiency resulted 
in lower input power being required to produce a given transmit field, which therefore 
reduced the local SAR throughout the body.
Despite the clear increase in SNR afforded by the use of the HP pads, it is important that 
their use does not introduce a measurement bias into the MTGC quantification. Our 
results showed statistically identical values without (0.39% [0.17%]) and with (0.38% 
[0.15%]) the HP pads (P = 0.83), meaning that lipid quantification is not affected by using 
the pads. The MTGC for the healthy volunteers was in agreement with previous stud-
ies.17–19
In conclusion, HP pads improve cardiac 1H-MRS at 3 T by increasing the SNR on average 
by 60%, which can be used to reduce data acquisition time, significantly allowing fast 
assessment of MTGC without compromising spectral quality. The same pads as the Brink 
and Webb (MRM 2014) study were used for this study. This set of pads was optimized to 
“maximize the average transmit efficiency and to minimize the B1 inhomogeneity (s), over 
the entire 3D heart volume”. As such, there may be some improvements that could be 













To optimize data acquisition parameters in cardiac proton MR spectroscopy, and to 
evaluate the intra- and intersession variability in myocardial triglyceride content. 
Materials and Methods:
Data acquisition parameters at 3 Tesla (T) were optimized and reproducibility measured 
using, in total, 49 healthy subjects. The signal-to-noise-ratio (SNR) and the variance in 
metabolite amplitude between averages were measured for: (i) global versus local power 
optimization; (ii) static magnetic field (B0) shimming performed during free-breathing or 
within breathholds; (iii) post R-wave peak measurement times between 50 and 900 ms; 
(iv) without respiratory compensation, with breathholds and with navigator triggering; and 
(v) frequency selective excitation, Chemical Shift Selective (CHESS) and Multiply Opti-
mized Insensitive Suppression Train (MOIST) water suppression techniques. Using the 
optimized parameters intra- and intersession myocardial triglyceride content reproduc-
ibility was measured. Two cardiac proton spectra were acquired with the same parame-
ters and compared (intrasession reproducibility) after which the subject was removed 
from the scanner and placed back in the scanner and a third spectrum was acquired 
which was compared with the first measurement (intersession reproducibility). 
Results:
Local power optimization increased SNR on average by 22% compared with global power 
optimization (P = 0.0002). The average linewidth was not significantly different for pencil 
beam B0 shimming using free-breathing or breathholds (19.1 Hz versus 17.5 Hz; P = 0.15). 
The highest signal stability occurred at a cardiac trigger delay around 240 ms. The mean 
amplitude variation was significantly lower for breathholds versus free-breathing (P = 
0.03) and for navigator triggering versus free-breathing (P = 0.03) as well as for navigator 
triggering versus breathhold (P = 0.02). The mean residual water signal using CHESS 
(1.1%, P = 0.01) or MOIST (0.7%, P = 0.01) water suppression was significantly lower than 
using frequency selective excitation water suppression (7.0%). Using the optimized 
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parameters an intrasession limits of agreement of the myocardial triglyceride content of 
−0.11% to +0.04%, and an intersession of −0.15% to +0.9%, were achieved. The coefficient 
of variation was 5% for the intrasession reproducibility and 6.5% for the intersession 
reproducibility. 
Conclusion:
Using approaches designed to optimize SNR and minimize the variation in inter-average 
signal intensities and frequencies/phases, a protocol was developed to perform cardiac 





Cardiac proton MR spectroscopy (MRS) can be used to study the effects of lipid accumula-
tion and lipid toxicity in the heart by means of quantitative measurement of the myocar-
dial triglyceride content (MTGC).1,2 This value is relevant in patients with metabolic 
syndrome and type 2 diabetes mellitus (DM2), because higher levels have been linked to 
an increased risk of heart failure.3 Because the metabolic syndrome and DM2 can 
potentially be reversed by therapy or diet, it is important to have a reliable and quantita-
tive way of measuring cardiac lipid accumulation. Currently, the application of MRS is 
limited to clinical research mainly due to the complexity of the technique in terms of the 
number of parameters which need to be optimized. These include breathing-motion 
compensation technique because motion due to breathing introduce dynamic variations in 
the local static magnetic field leading to an increase in spectral linewidth and decrease in 
the signal-to-noise ratio (SNR) of the lipid peaks.
Similar effects are seen due to the motion related to the cardiac cycle, deformation of the 
septum as well as the in- and outflow of blood, therefore, the acquisition must be trig-
gered to the cardiac cycle. Transmit field (B1+) inhomogeneity across the heart leads to 
under- or overestimation of the tip angle in the myocardial wall if conventional global 
power optimization routines are used, and subsequently lead to loss in the SNR.4,5 It has 
also been shown that the nonuniform flip angle distribution results in sections of the free 
right ventricular wall and the mid-ventricular and apical septum being obscured.6,7 The 
low abundance of lipid protons (generally  100 times less abundant than water protons) 
means that many signal averages must be acquired, and a high degree of phase stability 
between averages is required for optimal SNR.2,8–11 Because the water signal is much 
larger than the lipid signal, the water signal needs to be efficiently suppressed to mini-
mize baseline distortions and spurious signals that otherwise complicate metabolite 
quantification due to vibration induced signal modulations.12
The aim of this study is to optimize five of the main parameters and methods used in 
cardiac proton MRS measurements, namely the method of RF power optimization, B0 
shimming, the measurement point within the cardiac cycle, the method of respiratory 
motion compensation and the choice of water suppression technique. The choices made 
also considered the requirement of minimal input from the user to make the overall 
protocol more robust in order to incorporate it into a clinical scan. Finally, we use these 
optimized parameters to assess the intra- and intersession reproducibility of cardiac 
MRS in healthy volunteers. 
MATERIALS AND METHODS
Participants
The study was approved by the institutional review board, and written informed consent 
was obtained from all participants. The study was conducted according to the principles 
expressed in the Declaration of Helsinki. Forty-nine healthy subjects underwent cardiac 
MRS between July 2013 and September 2015.
Data Acquisition
Experiments were performed on a 3 Telsa (T) Ingenia whole-body MRI scanner (Philips 
Healthcare, Best, Netherlands). The body coil was used for transmission and an anterior 
(16 elements) and a posterior (12 elements) array for reception. The most commonly used 
sequence in cardiac MRS is point resolved spectroscopy (PRESS)8,13–16 due to its availabil-
ity as a standard “product sequence” on commercial platforms, and the fact that it gives 
twice the SNR of the stimulated echo acquisition method (STEAM) method.17 Two disad-
vantages of PRESS localization compared with STEAM are the increased chemical shift 
displacement and increased minimal echo time.
However, because for this study we were mainly interested in a small chemical shift 
range of the lipid peaks (CH2)
n at 1.3 ppm and CH3 at 0.9 ppm), this will result in only a 
minor mismatch in the location of the two metabolites. If both the lipids (1.3 ppm) as well 
as creatine (3 ppm) are of interest, care should be taken planning the spectroscopy voxel 
to ensure the creatine still falls within the septum. The water signal (4.7 ppm) used as a 
reference for the lipid quantification does have a significantly different chemical shift; 
however, data for non–water-suppressed spectra are acquired with a different transmit-
ter offset, resulting in overlap of the spectroscopic volume of interest (VOI) of the lipid- 
and water-acquisition. The increased minimal echo time does negate the theoretical 
double SNR of PRESS localization compared with STEAM; however, this effect is only 
large when the T2 of the metabolite of interest low. In a previous study, it has been shown 
that the use of a high permittivity pads increases the SNR of localized cardiac spectra 
without affecting spectral linewidth.18 A similar arrangement was used in this study. A 
first order pencil beam shimming technique was used to shim the static magnetic field 
(B0). This technique requires minimal user input and reconstructs the B0 distribution in 
the spectroscopy voxel by capturing multiple (nine) projections.
A 30 s survey and a single breathhold coronal image were acquired to plan the navigator 
volume. Four-chamber and shortaxis cine images were acquired to plan the MRS voxel in 
the myocardial interventricular septum. Spectra were recorded using PRESS localization 
with an echo time (TE) of 35 ms and a repetition time (TR) of 9 s for the non–water-sup-
pressed spectra, and 3.5 s for the water-suppressed spectra to ensure full relaxation of 
the water and lipid signals. The spectroscopic VOI (15 x 25 x 40 mm3) was placed in the 
interventricular septum and pencil beam B0 shimming was performed on this VOI. The 
bandwidth of the MRS acquisition was 1500 Hz and 2048 samples were acquired resulting 
in spectral resolution of 0.73 Hz / sample. Five different parameters were optimized as 
described below:
Power Optimization.
Spectra were acquired in 15 subjects comparing the standard system “global” power 
optimization with “local” power optimization. Global in this case refers to the fact that 




verse slice through the heart, whereas local applies only to the spectroscopic VOI. It is 
well-known that there is substantial variation in the transmit (B1
+) field through the body 
(and within the heart itself ) at 3 T, and so global power optimization is unlikely to result in 
the correct tip angles within the spectroscopic VOI.4 Previous studies reported a variation 
in B1
+ of 100% over the short axis of the heart.5–7 Local power optimization method was 
performed by monitoring the intensity of the water peak and incrementing the tip angles 
of the excitation pulse and the two refocusing pulses in the PRESS sequence in steps of 
5% (range, 90%–150% of the global power optimization result), and choosing the power 
which produced the maximum signal intensity. The SNR of the water signal was compared 
for the local and global power optimization using a Wilcoxon signed-rank test.
Comparison of Spectral Linewidth for Freebreathing and Breathhold B0 Shimming.
First order B0 pencil beam shimming (nine projections) was performed during freebreath-
ing and in two breathholds of 13 s (max. five projections per breathhold) in eight healthy 
subjects, after which non–watersuppressed spectra (four averages) were acquired. The 
full width at half maximum (FWHM) of the water peak was determined for each spectrum 
and compared using a Wilcoxon signed rank test. To determine the reproducibility of the 
B0 shimming, each scan was repeated three times in each subject and the standard 
deviation determined for these three measurements.
Amplitude Stability as a Function of the Measurement Point within the Cardiac Cycle.
Non–water-suppressed spectra (16 averages) were acquired in three subjects at eight 
different times (50, 150, 200, 250, 300, 500, 700, and 900 ms) after the peak of the R-wave. 
The variation of the signal was determined by calculating the standard deviation of the 
water signal amplitude. The average heart rate was recorded for each subject. 
Comparison of Signal Reproducibility Between Freebreathing, Breathhold, and Navigator 
Triggering.
Non–water-suppressed spectra (16 averages) were acquired in seven subjects with 
free-breathing, breathholds and navigator triggered respiratory compensation.13 The 
breathhold acquisition was performed in eight breathholds of 18 s acquiring two averages 
per breathhold. The navigator volume was placed on the lung– liver interface and had a 
gating window of 3 mm. The navigator triggers the spectroscopy sequence and tracks the 
position of the diaphragm updating the spectroscopy voxel location dynamically with 
respect to the actual position of the heart. The stability of the amplitude was determined 
by calculating the standard deviation of the signal for the three respiratory compensation 
methods. The variations of the center frequency and phase of the water signal were also 
determined. The amplitude variation, center frequency variation, and phase variations for 
the three different methods were compared using Friedman’s test and post hoc Wilcoxon 
signed rank test.
Efficiency of Different Water Suppression Methods.
Three different water suppression techniques were assessed in eight subjects: frequency 
selective excitation,19 Chemical Shift Selective (CHESS)20,21 and Multiply Optimized 
Insensitive Suppression Train (MOIST) water suppression.22 Frequency selective exci-
tation water suppression uses two selective RF pulses combined with crusher gradients 
to minimize the water magnetization at the beginning of the acquisition. CHESS water 
suppression uses three narrowband chemical shift selective pulses, while MOIST water 
suppression uses four phase-modulated RF pulses, such that the longitudinal magnetiza-
tion of the water signal is minimized at the beginning of the acquisition. Four non–
water-suppressed averages and 16 water-suppressed averages were acquired for each 
subject. A residual water fraction was calculated by dividing the water signal in the 
suppressed spectrum by the water signal in the non–watersuppressed spectrum. A 
Friedman’s test was performed to analyze differences in the residual water signal 
between the three water suppression techniques, and post hoc tests were performed with 
the Wilcoxon signed-rank test. Spectra were also visually inspected to assess spectral 
quality in terms of baseline distortion and the presence of spurious signals from incom-
plete water suppression. 
Assessment of the Inter- and Intrasession Reproducibility of MTGC Quantification
Using the optimized parameters derived in the results section, spectra (6 averages 
without water suppression, 32 averages with water suppression) were acquired in eight 
subjects. The MTGC was calculated from the formula:
The scan was then repeated and the MTGC of the two scans compared with determine the 
intrasession reproducibility. In seven of the eight cases (one was not possible due to a 1 h 
time limit on scanning), the subject was then fully removed from the scanner, positioned 
back on the patient bed, and the protocol was re-run to determine the intersession 
reproducibility. To determine the intersession reproducibility, spectra were compared 
with the first scan acquired. The coefficient of variation (CV) was determined and the 
Spearman correlation coefficient was calculated to determine the intra- and intersession 
correlation and Bland-Altman plots were constructed.
Data Processing
All spectra were fitted in the time-domain using the Java-based MR User Interface 
(jMRUI).23 The advanced method for accurate, robust and efficient spectral fitting (AMA-
RES) algorithm was used to fit the resonances to a Gaussian line shape. The water and 
lipid SNRs were defined as the integrated area under the water peak and the sum of the 
integrated area under the triglyceride-methyl (CH3) and the triglyceride-methylene (CH2)
n 
peaks, divided by the standard deviation (SD) of the noise, respectively. The noise was 
taken from the last 100 points of the free induction decay.
Statistical Analysis
All statistical analyses were performed using the statistical software IBM SPSS Statistics 
(version 20, IBM, Chicago, IL). Plots were created using GraphPad Prism (GraphPad 
Software, San Diego, CA). Numerical data were reported as mean ± standard deviation. 
Data were considered statistically significant at P-values  0.05. 
MTGC =
triglyceride methyl (CH3) + triglyceride methylene (CH2)n
water +  triglyceride methyl (CH3) + triglyceride methylene (CH2)n
× 100%  (Equation 1)
The scan was th n repeated and the MTGC of t e two ca s compared with det rmine t e 
intrasession reproducibility. In seven of the eight cases (one was not possible due to a 1 h
time limit on scanning), the subject was then fully removed from the scanner, positioned 
back on the patient bed, and the protocol was re-run to determine the intersession 
reproducibility. To determine the intersession reproducibility, spectra were compared with 
the fir t s an acquired. The coefficient of variation (CV) was determined and the Spearman 
correlation coefficient was calculated to determine the intra- and intersession correlation and 
Bland-Altman plots were constructed.
Data Processing
All spectra were fitted in th  tim -d main i  t  J va-based MR User Interface (jMRUI).23
The adv nced method for acc rate, robust and fficient spectral fitting (AMARES) algorithm 
was used to fit the resonances to a Gaussian line shape. The water and lipid SNRs were 
defined as the integrated area under the water peak and the sum of the integrated area 
under the triglyceride-methyl (CH3) and the triglyceride-methylene (CH2)n peaks, divided by 
the standard deviation (SD) of the noise, respectively. The noise was taken from the last 100 
points of the free induction decay.
Statistical Analysis
All statistical analyses were performed using the statistical software IBM SPSS Statistics 
(version 20, IBM, Chicago, IL). Plots were created using GraphPad Prism (GraphPad 
Software, San Diego, CA). Numerical data were reported as mean ± standard deviation. 






Figure 1 shows water-suppressed spectra acquired using global and local power optimi-
zations in a male subject with a body mass index (BMI) of 30.3 kg/m2. The SNR of the lipid 
increased from 17 to 38 arbitrary units (a.u.) using the local power optimization compared 
with the global power optimization. Figure 2 plots the SNR of the water signal for all 15 
subjects. The spectra of 13 of the 15 subjects show a higher SNR using local power 
optimization compared with global power optimization, while for the remaining two 
subjects the SNR did not differ. The mean SNR (±SD) of the water signal was 1787 (±787) 
using global power optimization versus 2173 (±626) for local power optimization (P = 
0.0002).
COMPARISON OF SPECTRAL LINEWIDTHS FOR FREE-BREATHING AND BREATHHOLD B0 
SHIMMING
The mean linewidth after performing pencil-beam B0 shimming during free-breathing 
was 19.1 Hz (±3.2 Hz) compared with 17.5 Hz (±4.6 Hz) when shimming was performed 
during breathholds: these values were not significantly different (P = 0.15). The mean of 
the standard deviation of the three successive linewidth measurements in each volunteer 
was 2.3 Hz (free-breathing) and 1.5 Hz (breathholds).
FIGURE 1: Cardiac MR spectrum acquired with global 
power optimization (left), a spectrum (right), in the same 
subject, is shown using local power optimization within the 
spectroscopic VOI.
FIGURE 2: SNR of the water signal for 
global- and local power optimization in 15 
subjects. The spectra of 13 of the 15 sub-
jects show a higher SNR using local power 
optimization compared with global power 
optimization, while for the remaining two 
subjects the SNR did not differ.
AMPLITUDE STABILITY AS A FUNCTION OF THE MEASUREMENT POINT WITHIN THE 
CARDIAC CYCLE
Figure 3 plots the standard deviation of the nonsuppressed water signal as a function of 
the cardiac trigger delay for three subjects. The average standard deviations were 0.18, 
0.06, 0.07, 0.06, 0.22, 0.34, 0.15, and 0.15 for a cardiac trigger delay of 50, 150, 200, 250, 
300, 500, and 700 ms, respectively. For all subjects, the SD had a minimum value, 
corresponding to the highest signal stability, at a trigger delay around 240 ms. This value 
agrees well with a previous study,24 which is why only a relatively small number of 
subjects were used for this particular optimization step.
FIGURE 3: Standard deviation of the water signal for eight 
measurement time points in the cardiac cycle. The lowest 
standard deviation and thus the most stable measurement 
point in the cardiac cycle is around 200 ms after the peak 





COMPARISON OF SIGNAL REPRODUCIBILITY BETWEEN FREE-BREATHING, BREATH-
HOLD, AND NAVIGATOR TRIGGERING
The mean variations of the amplitude (P = 0.001), frequency (P = 0.001) and phase (P = 
0.016) of the water peak were significantly different for the three different breathing 
compensation methods (Figure 4). The mean amplitude variation was significantly lower 
for breathholds versus free-breathing (0.09 versus 0.22; P = 0.03) and for navigator 
triggering versus free-breathing (0.06 versus 0.22; P = 0.03), as well as for navigator 
triggering versus breathhold (0.06 versus 0.09; P = 0.02).
The mean variation of the water peak center frequency was 4.81 Hz (±5.18 Hz), 2.86 Hz 
(±2.82 Hz), and 1.37 Hz (±0.71 Hz) using free-breathing, breathholds, and navigator 
triggering, respectively (P = 0.008). The center frequency variation was significantly lower 
for breathholds versus free-breathing (P = 0.05) and for navigator triggering versus 
free-breathing (P = 0.02). The mean (SD) variation of the signal phase was 0.22 radians 
(±0.07 radians), 0.13 radians (±0.05 radians), and 0.12 radians (±0.02 radians) using 
free-breathing, breathholds, and navigator triggering, respectively (P = 0.016). The center 
frequency variation was significantly lower for breathholds versus free-breathing (P = 
0.05) and for navigator triggering versus freebreathing (P = 0.02).
EFFICIENCY OF WATER-SUPPRESSION METHODS
Figure 5 shows three water-suppressed spectra with the three different suppression 
techniques in the same subject. The Friedman’s test showed significant differences in the 
residual water signal for frequency selective excitation, CHESS, and MOIST water 
suppression techniques (P = 0.001). Figure 6 shows the results from all subjects. The 
mean residual water signal was 7.0% (4.8%) using frequency-selective excitation, 1.1% 
(0.9%) using CHESS water-suppression, and 0.7% (0.4%) using the MOIST technique. Both 
the MOIST (P = 0.01) and CHESS (P = 0.01) techniques gave significantly lower residual 
water signals than the frequency selective excitation sequence, but there was no statisti-
cal significance between MOIST and CHESS (P = 0.46).
FIGURE 4: Variations in the amplitude, center frequency, 
and phase of the water signal over 16 acquisitions for 
free-breathing and two methods of motion compensation. 
The Friedman’s test showed significant differences for the 
amplitude variation (P = 0.001) (left), center frequency 
variation (P = 0.001) (middle), and phase variation (P = 
0.016) (right). Post hoc tests showed that variations in the 
mean amplitude, center frequency and phase were signifi-
cantly different between free-breathing versus breath-
holds as well as between free-breathing versus navigator 
triggering. The mean of the amplitude variation was also 
significantly different between breathholds and navigator 
triggering.
Due to the poor suppression the selective excitation sequence often introduced a signifi-
cant baseline distortion in the spectrum, making MTGC quantification more difficult. In 
terms of choosing between the CHESS and MOIST techniques, the CHESS sequence is 
relatively long, requiring an increase in the suppression bandwidth to 240 Hz to be able to 
use a cardiac trigger delay of 200 ms. The length of the MOIST sequence is less than that 
of CHESS, requiring a lower suppression bandwidth of 190 Hz for a trigger delay of 200 
ms. Given this, and the slightly higher degree of water suppression, the MOIST sequence 
was used for MTGC quantitation. 
FIGURE 5: Water-suppressed spectra using three different 
water suppression techniques in the same subject. The 
residual water signal was calculated by dividing the water 
peak amplitude from the suppressed spectrum by that in 
the unsuppressed spectrum.
FIGURE 6: Residual water signal for the 
three different water suppression tech-
niques for all the subjects studied. The 
residual signals for frequency selective 
excitation and CHESS water suppression 
were significantly different, as were those 





ASSESSMENT OF THE INTER- AND INTRASESSION REPRODUCIBILITY OF MTGC QUAN-
TITATION
Figure 7 shows three spectra acquired from the same volunteer using the optimized scan 
parameters determined in the previous sections. The spectra on the left and center of 
Figure 7 were acquired in a single scan session to determine the intrasession reproduc-
ibility. The spectrum on the right was acquired in a separate scan session to determine 
the intersession reproducibility. The mean (±SD) MTGC of the intrasessions (n = 8) was 
0.55% (±0.40%) and 0.59% (±0.42%), with a correlation coefficient r = 1.000 (P  0.0001). 
The coefficient of variation for the intrasession reproducibility was 5% and the Bland-Alt-
man analysis showed a mean difference of 0.04% with limits of agreement from -0.11% to 
+0.04% (Figure 8A). The mean (±SD) MTGC of the intersessions (n = 7) was 0.60% (±0.42%) 
and 0.63% (±0.45%) with a correlation coefficient r = 1.000 (P = 0.0004). The coefficient of 
variation for the intersession reproducibility was 6.5% and the Bland-Altman analysis 
showed a difference of 0.03% and limits of agreement from -0.15% to +0.9% (Figure 8B). 
DISCUSSION
This study looked at the effect of several different data acquisition parameters with the 
aim of being able to perform reproducible cardiac proton spectroscopy on a clinical 3 T 
platform. In terms of SNR, using local rather than global power optimization showed a 
significant increase. Indeed, from the 15 subjects studied there were five cases that 
resulted in a SNR gain of 35% or more which is in line with a prior study.25 Local power 
optimization requires no changes to the system software, and so is easy to implement in a 
clinical setting. We observed that the power underestimation from a global power 
measurement was greatest in subjects with either high BMI or athletic subjects with high 
lung volume, but further study would be required to confirm this observation.
With respect to spectral quality, i.e., linewidth and lineshape, there was no statistical 
difference between performing B0 shimming during free-breathing or breathholds. In this 
study we did not compare image-based shimming to the pencil beam technique because 
the former technique is not implemented on most clinical systems. In the future, this 
would be interesting to investigate because image-based shimming is generally more 
robust and gives improved linewidths in cardiac imaging.25
With respect to spectral reproducibility (and SNR because individual spectra are 
co-added in signal averaging), the key parameters are the measurement point within the 
cardiac cycle, and the form of motion compensation used. In previous publications some 
authors have measured in systole and others in the diastolic phase.8,9,16,26 The results in 
this study show that the beginning of the systolic heart phase (200–250 ms after the peak 
of the R-wave) has the highest stability: this agrees well with the findings of a previous 
study.24 Given that the range of heart rates was not extensive (range, 46–67 bpm) the 
optimal measurement point was only minimally affected by the heart rate for these 
subjects, which can be explained by the small influence of the heart rate on the length of 
the systolic heart phase.27
In another study of Weiss et al, it was shown that the maximum SNR in cardiac spectros-
copy was achieved in midsystole with a trigger delay  300 ms. However, mid-systole is 
relatively close to the point that the stability of the signal decreases strongly.28 In that 
study, they also propose an improved spectroscopy sequence to decrease the sensitivity 
of the sequence to cardiac motion, using very strong crusher gradients. In earlier studies, 
it was also shown that respiratory compensation should be used to increase the repro-
ducibility of cardiac MRS.13,29,30 Our results show that, by using breathholds, it is possible 
to increase the signal stability significantly. However, the navigator-based respiratory 
compensation resulted in significantly lower variations in signal intensity and signal 
frequency/phase than using breathholds. In addition, many classes of patients have 
problems maintaining breathholds for prolonged periods of time. Therefore, the naviga-
tor-based respiratory compensation is preferred over breathhold.
With respect to water suppression, the CHESS and MOIST techniques both showed 
suppression ratios of approximately 100:1, with MOIST giving slightly better water 
suppression and more consistent results. However, MOIST is a manufacturer specific 
variant on the CHESS sequence in terms of parameter optimization. Because no statisti-
cal difference was measured between the two techniques, the more standard CHESS 
sequence may be able to be substituted where necessary.
Using the optimized protocol proposed in this study, it was possible to get an intersession 
reproducibility of the MTGC of 6.5% which is in line with the findings of Ith et al.31 It should 
be noted that in that study the creatine signal was used as a reference whereas in our 
FIGURE 7: Left and center: Two spectra acquired succes-
sively are shown to calculate the intrasession reproduc-
ibility. Right: A spectrum from the same volunteer 
acquired in a different scanning session to assess the 
intersession reproducibility.
FIGURE 8: Bland-Altman plots for both intra- and interses-
sion reproducibility. The Spearman correlation coefficient 
was 1.000 for both the intersession (left) and intrasession 
(right) measurements. The intrasession reproducibility 
mean difference was 0.04% with limits of agreement from 
-0.11% to +0.04%. The intersession reproducibility mean 





current study we used the water signal. The reproducibility reported here is also much 
higher than other studies performed at 1.5 T. For example, it was shown by Felblinger et 
al that, by using the ECG electrodes to measure the respiratory phase while an optical 
ECG sensor was used to measure the cardiac cycle, it was possible to get an intersession 
coefficient of variation of 13%. Szczepaniak et al showed that using a respiratory pressure 
belt and ECG triggering it was possible to get an intersession coefficient of variation of 
17%.30 In van der Meer et al, the coefficient of variation was 17.9% using navigator-based 
respiratory compensation.8 With the optimized protocol proposed in this study the limits 
of agreement for the Bland Altman analysis lay between −0.15% and +0.9% compared with 
−0.14 and +0.19 for the study performed by van der Meer et al.
In terms of study limitations, one is that we have only provided optimized parameters for 
the measurement location in the myocardial septum, which is a relevant region for 
studying the effects of metabolic syndrome and type 2 diabetes mellitus but not for 
localized tissue changes such as myocardial infarcts. In this study, the total group of 
volunteers was relatively large: however, because there were multiple topics of interest 
the sample size for each individual topic were smaller. We also note that this study was 
performed on healthy subjects where the efficiency of the navigator is high (around 50%) 
but some patients tend to have irregular breathing patterns that will most likely result in 
decreased navigator efficiency and increased scan time.
In conclusion, using the optimized protocol with local power optimization, pencil beam B0 
shimming, a cardiac trigger delay of 200 ms, pencil beam navigator-based respiratory 
compensation, and MOIST water suppression, we were able to achieve an high intra- and 
intersession reproducibility of the MTGC. The preparation time of the spectroscopy scan 
was 1 min and 3 s (power optimization 3 s, resonance frequency determination 24 s, and 
pencil beam B0 shimming 36 s), and the acquisition of the spectra (4 unsuppressed 
averages and 32 suppressed averages) was 4 min and 24 s with an navigator efficiency of 
50%. This resulted in an average total scan time of 5.5 min.
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MR OF MULTI-ORGAN 






•	 State-of-the-art magnetic resonance (MR) technologies provide whole-body assess-
ment of metabolic syndrome (MetS) pathophysiology and complications.
•	 MRI and MR spectroscopy image and quantify ectopic lipid accumulation, such as 
pericardial/perivascular fat, visceral abdominal fat, and fatty infiltration of organs, 
associated with adverse outcome.
•	 By using MR elastography, T1-mapping, phosphorus MR spectroscopy, and diffu-
sion-weighted imaging, MR can assist in staging nonalcoholic fatty liver disease.
•	 Using cardiac MRI, spectroscopy, and mapping techniques, key features of diabetic 
cardiomyopathy, such as diastolic dysfunction, left ventricular hypertrophy, myocardial 
steatosis and fibrosis, can be quantified.
•	 Novel MR techniques, such as magnetization transfer imaging and diffusion tensor 
imaging, demonstrate microstructural brain damage in MetS.
MR OF MULTI-ORGAN INVOLVEMENT IN THE METABOLIC SYNDROME
Adapted from Magnetic Resonance Imaging Clinics of North America. 2015 
Feb;23(1):41-58.
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About one-third of the United States population of 20 years or older has metabolic 
syndrome (MetS) and its prevalence increases with advancing age and body mass index,1 
stressing its tight association with the obesity epidemic.
Definition
Diagnosis of MetS requires positive identification of at least 3 out of 5 criteria displayed in 
Table 1.
Table 1  Diagnosis of MetS
MetS Criteria (NCEP-ATP III Criteria) Definition 
Abdominal obesity: waist circumference Men  40 inches 
Women  35 inches 
Increased plasma triglyceride level  150 mg/dL 
Decreased plasma HDL level Men  40 mg/dL 
Women  50 mg/dL 
Elevated blood pressure  130/85 mm Hg 
Increased plasma fasting glucose  100 mg/dL 
As such, approximately 90% of type 2 diabetes mellitus (DM2) patients have MetS.1 
Patients with MetS are heterogeneous in nature with varying risk of disease and conse-
quently require personalized care, for example, by MR prognosis, in terms of future 
cardiovascular and cerebrovascular events (Figure 1).2
MRI of Multi-Organ Involvement in the Metabolic Syndrome
MetS is a systemic disease with complex pathophysiology including insulin resistance, 
atherogenic dyslipidemia, hypertension, ectopic lipid accumulation, low-grade inflamma-
tion, prothrombotic state, and fibrosis resulting in end-organ damage.3 MRI and magnetic 
resonance spectroscopy (MRS) can be used to quantify ectopic lipid accumulation. 
Importantly, as shown in Figure 2, functional and structural consequences of MetS can be 
evaluated with MR on a whole body level. In the liver, several techniques — ranging from 
MRS and water-fat imaging to magnetic resonance elastography (MRE) and T1 mapping 
—are used to quantify hepatic steatosis and differentiate between stages of nonalcoholic 
fatty liver disease (NAFLD). In parallel, cardiac MR can quantify myocardial steatosis and 
associated complications, such as diastolic dysfunction and fibrosis. In the brain, magnet-
ization transfer imaging and diffusion tensor imaging (DTI) can detect microstructural 
brain damage associated with MetS. The involvement of various other organs ranging 




FIGURE 1. Clinical whole-body MR for risk estimation of 
future cardiovascular events. Images acquired in a 74-year 
old man with a 21-year history of type 2 diabetes mellitus. 
(A) Cardiac MRI involving cine imaging (top and middle) 
showing hypokinesia in the anterolateral segment (arrow). 
The bottom image is a late gadolinium enhanced image 
displaying subendocardial enhancement (arrowhead) 
consistent with myocardial infarction. (B) Cerebral arter-
ies using time-of-flight angiography (top), an axial 
T2-weighted brain image (middle) and a coronal fluid-at-
tenuated inversion-recovery image (bottom). These images 
show no overt brain abnormalities associated with the 
metabolic syndrome (MetS). (C) Contrast-enhanced MR 
angiograms of carotid arteries (left) and abdominal and 
lower extremity arteries (right) with arrowhead and 
arrows indicating stenosis owing to atherosclerotic dis-
ease. Using this 60-minute MR protocol, future cardiac and 
cerebrovascular events can be predicted in DM patients 
with higher accuracy compared with clinical characteris-
tics.1 (From Bamberg F, Parhofer KG, Lochner E, et al. 
Diabetes mellitus: long-term prognostic value of whole-
body MR imaging for the occurrence of cardiac and cere-
brovascular events. Radiology 2013;269(3):733, with 
permission.)
FIGURE 2. Overview of MR assessment of multi-organ 
involvement in metabolic syndrome. Key features of 
multiorgan involvement in the metabolic syndrome (MetS) 
that can be assessed with MR are shown. MRI accurately 
assesses the distribution of WAT showing an abundance of 
visceral adipose tissue (VAT) and peri-organ adipose 
tissue. In contrast, brown adipose tissue volume is dimin-
ished in obesity, suggesting that diminished thermogene-
sis may be involved in the etiology of MetS. Excessive 
accumulation of triglycerides in the liver, that is, hepatic 
steatosis, may play a central role in the development of 
MetS. Hepatic steatosis can progress into nonalcoholic 
steatohepatitis (NASH), fibrosis, and cirrhosis. Both 
excessive VAT and hepatic steatosis are strongly linked to 
insulin resistance, a key component of MetS. The cardio-
vascular system can be involved focally (eg, myocardial 
infarction) or globally (eg, diabetic cardiomyopathy). 
Cardiac remodeling of the cardiovascular system involves 
the sequelae of fatty infiltration, inflammation, fibrosis, 
and ultimately organ failure. Furthermore, brain involve-
ment in MetS is increasingly being studied. In addition to 
macrostructural changes, such as brain atrophy and 
cerebral small vessel disease, microstructural changes 
are important features of MetS brain pathology. Various 
other organs, such as the kidney, pancreas, and skeletal 
muscle, undergo pathologic alterations in MetS patients. 





This review highlights MR techniques that assess multi-organ involvement in MetS.
ADIPOSE TISSUE
White Adipose Tissue
Abdominal visceral obesity Ectopic lipid accumulation in white adipose tissue (WAT) 
predominantly occurs in the visceral abdominal compartment. Visceral white adipocytes 
can contribute to MetS etiology by secreting excessive amounts of plasma free fatty acids, 
adipokines, and cytokines. MetS prevalence correlates with waist circumference, 
reflecting the role of abdominal obesity. However, waist circumference does not differen-
tiate between subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT). Given 
that VAT has a stronger association with MetS than SAT, differentiation between SAT and 
VAT is critical.3 Several MR techniques can be used to reliably quantify SAT and VAT. These 
include T1-weighted imaging, frequency-selective lipid imaging, and chemical-shift-en-
coded water–fat imaging, all different methods that can be lumped under the umbrella of 
water–fat MRI (Figures 3 and 4). An appropriate sequence can be chosen on the basis of 
local accessibility, available scanning time, and presence of image post-processing 
expertise. An overview of MR techniques for lipid quantification and their advantages/
disadvantages is reviewed by Hu and Kan.4 
FIGURE 3. Chemical shift imaging of abdominal adipose 
tissue and subsequent volume quantification. Transverse 
slice at the level of L5 vertebra acquired with an mDIXON 
method using 2 echoes, (A) 1 in-phase and (B) 1 out-of-
phase image. From these images, (C) a water image and 
(D) fat image can be reconstructed. (E) Image post pro-
cessing can be used to semi automatically assess subcuta-
neous (green) and visceral (red) adipose tissue. This 
sequence was performed in a patient with longstanding 
type 2 diabetes mellitus showing relatively large amounts 
of visceral adipose tissue compared with subcutaneous 
adipose tissue.
FIGURE 4. Frequency selective imaging of pericardial fat. 
Three-chamber view acquired with a turbo spin echo 
sequence with a spectral presaturation with inversion 
recovery (SPIR) and black blood prepulse sequence during 
1 breath-hold at 3 T. This high-resolution sequence ena-
bles separate quantification of epicardial (arrow) and 
paracardial (arrowhead) fat volumes. Note the high para-
cardial fat mass in this male patient with type 2 diabetes 
mellitus. In addition to their different anatomic relation to 
coronary arteries, epicardial and paracardial fat have a 
different embryonic origin; epicardial fat has brown 
adipose tissue characteristics, whereas the paracardial fat 
does not. Therefore, separate quantification of epicardial 





Pericardial and perivascular fat
In addition to abdominal VAT, ectopic lipid accumulation around the heart (pericardial fat) 
and vessels (perivascular fat) is increased in MetS. Pericardial/perivascular fat is 
physiologically protective in terms of mechanical support and as a source of biochemical 
substrates, hormones, and cytokines. However, increased pericardial/perivascular lipid 
accumulation in MetS has been linked with low-grade systemic inflammation, adverse 
FIGURE 5. Proton magnetic resonance spectroscopy 
(1H-MRS) of the liver to quantify hepatic triglyceride con-
tent. Voxel planning and examples of proton spectra 
acquired from the liver at 3 T. 1H-MRS is based on the fact 
that different molecules have different chemical environ-
ments that translate to small differences in the strength of 
the magnetic field for the different metabolites. This effect 
is commonly known as chemical shift. In the recorded 
spectrum, the difference in magnetic field results in 
different resonance frequencies, expressed in parts per 
million (ppm) with respect to that of tetrametylsilane, for 
the various metabolites. In practice, 1 spectra without 
water suppression is recorded to use as an internal refer-
ence, and 1 or more with water suppression are acquired 
for quantification of triglycerides (TG). To be able to meas-
ure small metabolite levels, it is necessary to measure a 
volume much larger than the normal pixel size in MRI. 
Upper panel, Typical 8-mL voxel for liver 1H-MRS. Lower 
panel, Acquired unsuppressed and water-suppressed 
spectra of an obese (left) and lean (right) volunteer. In liver 
spectra, TG is mainly represented by 3 different proton 
moieties, namely, CH2-CH = CH-CH2, (-CH2)
n, and -CH3. To 
quantify the fat percentage often the integrals below the 
(-CH2)
n and CH3 peaks are summed and divided by the sum 
of the integrals of the water and (-CH2)
n and CH3 peaks. In 
this example, the calculated hepatic triglyceride content 
was 8.26% for the obese subject and 1.24% for the lean 
subject. 
metabolic profile and risk of ischemic heart disease.5 Various electrocardiogram-gated 
MR sequences, including steady-state free precession short axis sequences, fat-selective 
imaging (see Figure 4), and water–fat MRI, can be used to image pericardial fat and 
enable volume quantification in a reproducible manner.1
Brown Adipose Tissue
In contrast to WAT, brown adipose tissue (BAT) volume and activity are diminished in 
obesity and may play a role in its development. BAT contributes significantly to total 
resting energy expenditure by dissipating glucose and free fatty acids into heat. The 
reference method for imaging BAT volume and activity is fluorodeoxyglucose PET-CT 
after mild cold exposure. The desire for a non-irradiating alternative has led to many MR 
techniques being evaluated to image BAT. These techniques identify BAT by its higher 
water fraction compared with WAT. However, MR of BAT is limited by the fact that, in 
humans, BAT and WAT are not entirely separated anatomically, complicating reliable BAT 
volume quantification. MRI of BAT activity is still in its infancy, although promising results 
using T2* imaging have been published recently.4
LIVER
Hepatic Steatosis
Ectopic lipid accumulation in the liver, that is, hepatic steatosis, is present in the majority 
of MetS patients and plays a central role in the pathogenesis of insulin resistance, 
hyperglycemia, and atherogenic dyslipidemia. The gold standard to determine hepatic 
steatosis is histology which requires a biopsy. However, several MR techniques can 
assess hepatic triglyceride (TG) content noninvasively with lower sampling error.1
Currently, proton MRS (1H-MRS) is the noninvasive gold standard to quantify hepatic TG 
content (Figure 5). 1H-MRS has the best sensitivity for detection of small amounts of fat. A 
drawback of this technique is the risk of sampling error inherent to quantifying TG content 
in a small voxel.
Recently, the mDIXON technique using multiple echoes has been shown to enable liver fat 
quantification (Figure 6). By applying the mDIXON technique, T2* effects caused by the 
relatively high iron content in the liver can be compensated. The technique is becoming 
FIGURE 6. DIXON MRI of the liver to quantify hepatic 
triglyceride content. The left and middle images are the 
reconstructed water and fat images, respectively. A 
6-point DIXON sequence was used with a starting echo 
time of 0.74 ms and echo spacing of 1 ms. The fat fraction 
was calculated on a pixel-by-pixel basis by dividing the fat 
image by the sum of the water and fat image. For this 
obese subject, the calculated fat fraction was between 3% 
and 9%, depending on the location, illustrating the inho-




FIGURE 7. Magnetic resonance elastography and T1 map-
ping: Quantitative imaging of hepatic fibrosis in nonalco-
holic fatty liver disease (NAFLD). Examples of T1 mapping 
(left) and magnetic resonance elastography (MRE; right) in 
healthy versus fibrotic liver tissue (as assessed by biopsy). 
T1 maps were acquired with a shortened modified Look-
Locker (shMOLLI) sequence in a single breath-hold. 
Increasing T1 values were correlated with increasing 
degrees of fibrosis. MRE is performed using mechanical 
waves transmitted by an acoustic pressure driver. Using 
automated post-processing, data are translated into 
quantitative images displaying tissue shear stiffness in 
kPa. It has been shown that MRE is a useful tool to detect 
advanced stages of fibrosis. The dotted lines indicate the 
liver. (From [Left] Banerjee R, Pavlides M, Tunnicliffe EM, 
et al. Multiparametric magnetic resonance for the non-in-
vasive diagnosis of liver disease. J Hepatol 2014;60(1):72, 
with permission; and [right] Kim D, Kim WR, Talwalkar JA, 
et al. Advanced fibrosis in nonalcoholic fatty liver disease: 
noninvasive assessment with MR elastography. Radiology 
2013;268(2):415, with permission.)
increasingly popular because of its advantages of small sampling error (because it is a 
whole-organ imaging technique) and fast data acquisition.
Multidimensional chemical shift imaging is a multivoxel 1H-MRS technique that measures 
a grid of multiple voxels, thus reducing sampling error. The disadvantage of chemical 
shift imaging is that data acquisition is slow and technically challenging.
Progression of Hepatic Steatosis into Inflammation, Fibrosis, and Cirrhosis
Hepatic steatosis can progress into nonalcoholic steatohepatitis, fibrosis, and ultimately 
cirrhosis and hepatic failure, a disease spectrum termed NAFLD. MRE, T1 mapping, 
phosphorus MRS (31P-MRS), and diffusion-weighted imaging (DWI) are the focus of 
ongoing research to differentiate between NAFLD stages and explore potential advan-
tages compared with histology, that is, lower sampling error and fewer complications.6
MRE (Figure 7) is an emerging technique that quantitatively images shear waves in the 
liver produced by external mechanical waves. A few validation studies have shown MRE’s 
capability of differentiating between stages of NAFLD.7
T1 mapping is more readily available than MRE in terms of commercially available 
imaging sequences. This technique is based on the increased T1 relaxation time of 
edematous (nonalcoholic steatohepatitis) and fibrotic tissue. In NAFLD, several studies 
have been performed, showing a strong correlation between increasing T1 and increasing 
stages of fibrosis (see Figure 7).8 In parallel with quantification of extracellular volume 
(ECV) expansion in cardiac imaging, ECV quantification in the liver is also feasible.9 
However, validation studies for ECV mapping to quantify liver fibrosis have yet to be 
published.
31P-MRS can quantify metabolites involved in cell membrane metabolism as well as 
regulators of fibrosis pathogenesis can be assessed (Figure 8). Additionally, hepatic 
energy metabolism can be assessed by quantifying high energy phosphates.10
DWI is a promising technique that measures water movement in extracellular space. 
Unfortunately, DWI is less reliable in the presence of fat, which limits its use in NAFLD. 
Future studies must focus on correcting for the influence of fat in order for DWI to 
become suitable for NAFLD staging.6
FIGURE 8. Phosphorus magnetic resonance spectroscopy 
(31P-MRS) of the liver to differentiate between simple 
steatosis, steatohepatitis, and cirrhosis. Upper panel 
(A–C), 31P spectra, acquired at 3 T, of simple steatosis (non-
alcoholic fatty liver [NAFL]), nonalcoholic steatohepatitis 
(NASH), and cirrhosis, respectively. This technique quanti-
fies markers of hepatocyte membrane integrity. Corre-
sponding liver biopsy specimens are shown in the lower 
panel (D–F). The ratio of NADPH/(PME + PDE) was signifi-
cantly lower in NAFL compared with NASH and cirrhosis, 
whereas the ratios of PE/(PME + PDE) and GPC/(PME + 
PDE) were higher in cirrhosis compared with NASH and 
NAFL. GPC, glycerophosphocholine; GPE, glycerophos-
phosrylethanolamine; NADPH, nicotinamide adenine 
dinucleotide phosphate; NTP, nucleoside triphosphate; PC, 
phosphocholine; PDE, phosphodiester; PE, phosphosetha-
nolamine; PEP, phosphoenolpyruvate; Pi, inorganic phos-
phate; PME, phosphomonoester; UDPG, uridine diphos-
phosglucose. (From Sevastianova K, Hakkarainen A, 
Kotronen A, et al. Nonalcoholic fatty liver disease: detec-
tion of elevated nicotinamide adenine dinucleotide phos-
phate with in vivo 3-T 31P MR spectroscopy with proton 





Cardiac MRI (anatomic, functional, angiography, perfusion, late gadolinium enhancement) 
is an important component in the assessment of a major complication of MetS, namely 
ischemic heart disease, which is reviewed elsewhere.11 This section covers MR tech-
niques to assess nonischemic remodeling in MetS, that is, “diabetic cardiomyopathy,” 
which is characterized by diastolic dysfunction, hypertrophy, disrupted cardiac energy 
metabolism, and ECV expansion related to myocardial fibrosis.
Diastolic Dysfunction
Diastole comprises a combination of active (energy- consuming) relaxation and passive 
compliance. In MetS, diastolic dysfunction is an early feature and independent predictor 
of mortality. Diastolic dysfunction is caused by altered myocardial energetics and by 
diminished ventricular compliance.1 MR using phase contrast imaging with velocity 
encoding is a robust technique to quantitatively assess diastolic function (Figure 9). 
Although the left ventricle (LV) has been the primary focus of research, recent findings 
show that right ventricular diastolic dysfunction is analogous to LV diastolic dysfunction.12
Hypertrophy
LV end-diastolic mass-to-volume ratio is tightly linked to markers of insulin resistance, 
indicating concentric LV remodeling in MetS.11 Figure 9 shows an example of LV mass 
quantification with MR.
Cardiac Energy Metabolism
Cardiac energy metabolism is crucial for both systolic and diastolic function. As such, 
alterations in myocardial energetics may constitute the first step in heart failure patho-
physiology.13 MRS enables in vivo quantification of myocardial energetics (Figure 10).
Myocardial steatosis
An increased storage of TG in cardiomyocytes is a hallmark of diabetic cardiomyopathy.1 
As shown in animal studies, increased storage of myocardial TG reflects an abundance of 
toxic lipids that impair cardiomyocyte integrity and function. Myocardial steatosis may be 
an early sign of diabetic cardiomyopathy, because it is an independent predictor of 
diastolic dysfunction. Importantly, myocardial steatosis and diastolic dysfunction are 
reversible, signifying a window of opportunity for therapeutic interventions aimed at 
preventing overt heart failure.1 MR is the only modality capable of quantifying myocardial 
TG content. Figure 11 shows an example of cardiac 1H-MRS spectroscopy.
High-energy phosphate metabolism: fuel for function
The human heart requires enormous amounts of adenosine triphosphate (ATP) as a 
primary carrier of chemical energy. As such, the phosphocreatine/ ATP ratio is an 
important indicator of cardiac energy reserve and metabolic efficiency. A decreased ratio 
is associated with diastolic and systolic dysfunction. The finding that, in DM2 patients with 
normal cardiac mass and function, the phosphocreatine/ATP ratio was decreased 
compared with healthy controls, reflects the possibility that disruptions in myocardial 
energetics might play a role in the pathogenesis of cardiomyopathies.13 Figure 12 shows 
an example of 31P-MRS of the heart. Up to now, the use of cardiac 31P-MRS has been 
limited to a research setting in experienced centers because of its complex acquisition.
FIGURE 9. Reversible cardiac manifestations in metabolic 
syndrome: hypertrophy and diastolic dysfunction. MR 
measures left ventricular (LV) mass and diastolic function 
reliably and quantitatively, enabling detection of, for 
example, the effects of nutritional interventions in rela-
tively small study populations. The upper left panel shows 
manual segmentation of myocardium in end-diastolic 
shorts axis images. Using dedicated software, LV mass 
can be calculated, showing that LV mass diminished in all 
type 2 diabetes mellitus patients after a 16-week very 
lowcalorie diet (VLCD). Decreased LV mass was tightly 
linked with improved diastolic function as reflected by an 
improved E/A ratio (E = early filling phase, A = atrial late 
filling phase). This parameter can be measured by using 
phase contrast MR with velocity encoding (lower right 
panel). By acquiring a 2-dimensional acquisition plane 
centered on the atrioventricular valve, a time–velocity or 
time–flow rate curve can be generated. Recent studies 
have shown an increased reliability of diastolic function 
assessment using 3-dimensional 3-directional velocity 
encoding with retrospective tracking to compensate for 
valve movement and changing flow direction throughout 
the cardiac cycle. * P  .001; † P  .05. (From [Left lower 
panel] van der Meer RW, Lamb HJ, Smit JW, et al. MR 
imaging evaluation of cardiovascular risk in metabolic 
syndrome. Radiology 2012;264(1):31, with permission; and 
[Right panel] Hammer S, Snel M, Lamb HJ, et al. Prolonged 
caloric restriction in obese patients with type 2 diabetes 
mellitus decreases myocardial triglyceride content and 





FIGURE 10. MR spectroscopy assessment of cardiac 
energy metabolism. The cardiomyocyte is represented in 
orange. FFAs and glucose, in a ratio of 3:1, are the primary 
sources of chemical energy for the production of ATP, 
which takes plays in the mitochondrion (blue). FFAs are 
either stored as TGs or oxidized (B-ox) to give acetyl-CoA. 
Glucose is glycolysed—in the presence of oxygen—to 
pyruvate, another substrate for acetyl-CoA, which enters 
the Krebs cycle for oxidative phosphorylation. This process 
provides energy required to form ATP. In the mitochon-
drion, ATP and Cr give rise to phosphocreatine (PCr), which 
diffuses to the myofibril, where it is converted into 
mechanical energy, under tight control of the Ca2+ flux. 
Note here that both systole and diastole require ATP. The 
colored boxes (yellow, green, and red) indicate opportuni-
ties for measurement with 1H, 31P and 13C MRS, respec-
tively. For 1H and 31P, see also Figures 15 and 16. Cardiac 
13C-MRS has not yet been performed in humans, but animal 
studies using hyperpolarized metabolic tracers have 
shown the feasibility of using cardiac 13C-MRS to assess 
fuel flux (B-ox, Krebs cycle, pyruvate). Acetyl-CoA, ace-
tyl-coenzyme A; ADP, adenosine diphosphate; ATP, ade-
nosine triphosphate; B-ox, ß-oxidation; Ca2+, ionized 
calcium; Cr, creatine; FFA, free fatty acid; GLUT4, glucose 
transporter type 4; PCr, phosphocreatine; TG, triglyceride 
content. (From Bizino MB, Hammer S, Lamb HJ. Metabolic 
imaging of the human heart: clinical application of mag-
netic resonance spectroscopy. Heart 2014;100(11):881–90; 
with permission.)
FIGURE 11. Cardiac proton magnetic resonance spectros-
copy (1H-MRS) to quantify myocardial steatosis. Cardiac 
1H-MRS was performed on 1.5 and 3 T MR systems using 
commercially available transceiver coils, and recently at 7 
T using custom-built detectors. Cardiac 1H-MRS is subject 
to motion artifacts owing to contraction and breathing. To 
overcome these issues, cardiac 1H-MRS is usually per-
formed with electrocardiographic gating and either 
breath-holding or free breathing with respiratory motion 
triggering/compensation. To prevent contamination of 
pericardial fat, the voxel of interest (VOI) is placed in the 
interventricular septum. The most commonly used pulse 
sequences are stimulated echo acquisition mode (STEAM) 
and point resolved spectroscopy (PRESS). The low abun-
dance of the various metabolites requires water suppres-
sion and acquisition of multiple averages resulting in 
relatively long scan duration. The water-suppressed 
spectrum displayed in the lower panel shows signals from 
creatine (Cr), triglycerides (TG) and trimethyl ammonium 
(TMA). In this example, 16 non–water-suppressed and 48 
water-suppressed averages were acquired at 3 T from a 





Another hallmark of diabetic cardiomyopathy is ECV expansion caused by collagen 
deposition, referred to as myocardial fibrosis. Fibrosis is associated with mortality and 
activation of the renin– angiotensin–aldosterone system11 and can be quantified using a 
modified Look Locker (MOLLI) or shortened MOLLI sequence.14,15 Using these sequences, 
native T1 mapping and postcontrast T1 mapping can be performed. By combining these 
images, fractional ECV can be quantified (Figure 13).
FIGURE 12. Cardiac phosphorus magnetic resonance 
spectroscopy (31P-MRS) to assess high-energy phos-
phates. Cardiac 31P-MRS at 1.5 T is performed by position-
ing a volume of interest (square box) over almost the entire 
heart (A, B); eliminating signal contamination from skele-
tal muscle is essential. The PCr/ATP ratio can be calcu-
lated from the spectrum (C) and is an important represen-
tation of cardiac energy reserve. In the metabolic 
syndrome (MetS), a decreased PCr/ATP ratio has been 
found before the onset of overt heart failure. ATP, adenos-
ine triphosphate; 2,3 DPG, 2,3-diphosphglycerate; PCr, 
phosphocreatine; PDE, phosphodiesters; ppm, parts per 
million. (From Bizino MB, Hammer S, Lamb HJ. Metabolic 
imaging of the human heart: clinical application of mag-
netic resonance spectroscopy. Heart 2014;100(11):881–90; 
with permission.)
FIGURE 13. MR acquisition and image after processing to 
evaluate fibrosis in diabetic cardiomyopathy. Modified Look 
Locker inversion recovery (MOLLI) sequence to determine 
T1 values of myocardium and subsequent use of precon-
trast and postcontrast T1 maps to calculate extracellular 
volume, acquired at 3 T. (A) The MOLLI experiment. This 
technique consists of 3 consecutive electrocardiogram 
triggered look locker (LL) experiments, with a three (1), 
three (2), and five (3) segment single-shot readout. 
Between each LL experiment, 4 heartbeats are used for 
magnetization recovery. (B, C) In total, within a 17–heart-
beat breath-hold, the longitudinal relaxation curve is 
sampled at 11 different inversion times. The images are 
reordered based on increasing inversion time, that is, the 
time between the inversion pulse and the readout. (D) The 
T1 map can be calculated by performing voxel wise fitting 
the signal intensity (SI): 
𝑆𝐼[𝑎.𝑢.]=𝐴−𝐵 × 𝑒−𝑇𝐼/𝑇1∗,	𝑇1=𝑇1∗((𝐵/𝐴)	−1)	. A commonly used 
variation on the MOLLI method is the shortened MOLLI 
(ShMOLLI), where only 2 consecutive electrocardio-
graph-triggered LL experiments are performed with a 5 
and 1 single shot read out. (E) The formula used to calcu-
late the extracellular volume fraction (ECV): 
The ECV is determined with a combination of native and 
postcontrast T1 mapping. The gadolinium-based contrast 
agent will distribute in the extracellular space of the 
myocardium. Therefore, a higher concentration of gadolin-
ium indicates a larger ECV, which could indicate more 
fibrosis. In the example given in this figure, acquired in a 
66-year-old type 2 diabetes mellitus patient with myocar-
dial infarction, the average ECV of the myocardium was 
0.34, or 34%, compared with 27% in healthy volunteers.
calculate extracellular volume, acquired at 3 T. (A) The MOLLI experiment. This technique 
consists of 3 consecutive electrocardiogram triggered look locker (LL) experiments, with a 
three (1), three (2), and five (3) segment single-shot readout. Between each LL experiment, 
4 heartbeats are used for magnetization recovery. (B, C) In total, within a 17–heart-beat 
breath-hold, the longitudinal relaxation curve is sampled at 11 different inversion times. The 
images are reordered based on increasing inversion time, that is, the time between the 
inversion pulse and the readout. (D) The T1 map can be calculated by performing voxel wise 
fitting the signal intensity (SI): [ . . ] = − × − / 1∗, 1 = 1∗(( / ) − 1). A commonly 
used variation on the MOLLI method is the shortened MOLLI (ShMOLLI), where only 2 
consecutive electrocardiograph-triggered LL experiments are performed with a 5 and 1 
single shot read out. (E) The formula used to calculate the extracellular volume fraction 
(ECV): = 1, , − 1, ,
1, , − 1, ,
(1 − ). The ECV is determined with a combination of 
native and postcontrast T1 mapping. The gadolinium-based contrast agent will distribute in 
the extracellular space of the myocardium. Therefore, a higher concentration of gadolinium 
indicates a larger ECV, which could indicate more fibrosis. In the example given in this 
figure, acquired in a 66-year-old type 2 diabetes mellitus patient with myocardial infarction, 
the average ECV of the myocardium was 0.34, or 34%, compared with 27% in healthy 
volunteers.
BRAIN INVOLVEMENT IN THE METABOLIC SYNDROME
Brain Structures Involved in Feeding Behavior
Multiple brain structures are functionally involved in the regulation of food intake. 
Homeostatic regulation of food intake is driven by inputs from the basal ganglia, thalamus, 
and hippocampus. Interestingly, a recent study found increased amygdalar and hippocampal 
volumes, as assessed by 3-dimensional T1-weighted MRI, in elderly obese individuals.16
The finding that these morphometric changes occurred in the amygdala and hippocampus 
but not in other brain structures that play a role in feeding behavior suggests that cognitive 
aspects may be of major importance in the regulation of feeding.16 Additional studies are
required to examine the mechanisms behind the observed morphometric changes.
Blood oxygen level–dependent (BOLD) functional MRI is a sensitive marker of brain 
activation. It has been shown previously that healthy, lean volunteers demonstrated a
significant dose dependent decrease of the BOLD signal in the hypothalamus after glucose 
ingestion.17 In patients with DM2, hypothalamic neuronal activity is altered, as demonstrated 
by the absence of a BOLD signal decrease after glucose ingestion.18 Recently it has been 




BRAIN INVOLVEMENT IN THE METABOLIC SYNDROME
Brain Structures Involved in Feeding Behavior
Multiple brain structures are functionally involved in the regulation of food intake. 
Homeostatic regulation of food intake is driven by inputs from the basal ganglia, thala-
mus, and hippocampus. Interestingly, a recent study found increased amygdalar and 
hippocampal volumes, as assessed by 3-dimensional T1-weighted MRI, in elderly obese 
individuals.16 The finding that these morphometric changes occurred in the amygdala and 
hippocampus but not in other brain structures that play a role in feeding behavior 
suggests that cognitive aspects may be of major importance in the regulation of feeding.16 
Additional studies are required to examine the mechanisms behind the observed morpho-
metric changes.
Blood oxygen level–dependent (BOLD) functional MRI is a sensitive marker of brain 
activation. It has been shown previously that healthy, lean volunteers demonstrated a 
significant dose dependent decrease of the BOLD signal in the hypothalamus after 
glucose ingestion.17 In patients with DM2, hypothalamic neuronal activity is altered, as 
demonstrated by the absence of a BOLD signal decrease after glucose ingestion.18 
Recently it has been shown that after following a very low-calorie diet for 4 days, the 
hypothalamus in DM2 patients responds to glucose ingestion similarly to that in healthy 
subjects.19 Because the hypothalamus is involved in the control of postprandial metabo-
lism, this may explain the strong metabolic improvement that can be observed in DM2 
patients upon caloric restriction.19 Future studies are needed to elucidate the fundamen-
tal mechanisms behind the hypothalamic response to glucose ingestion.
Structural Brain Damage
Although cardiovascular disease is considered to be the main long-term complication of 
MetS, multiple organs may be affected, including the brain.1 Risk factors associated with 
MetS accelerate cerebral small vessel disease, which may result in white matter lesions, 
cerebral microbleeds, and brain atrophy, as detected by conventional structural MRI.20 
Subtle microstructural brain damage may occur in the normal appearing brain tissue in 
the absence of overt brain abnormalities.21
DTI is an MRI technique that is well suited to detect early microstructural changes in 
normal appearing brain tissue in a number of disease states. Using DTI, Shimoji and 
colleagues22 recently found that fractional anisotropy (FA) values were lower in MetS 
subjects relative to control subjects. FA reflects the “coherence” of highly structured 
tissue, such as axon bundles. Accordingly, lower FA values indicate microstructural brain 
tissue decline. Regional brain analysis showed that mean FA values of the right inferior 
fronto-occipital fasciculus were lower in MetS subjects compared with controls sub-
jects.22 The inferior fronto-occipital fasciculus connects all 4 major lobes of the brain and 
may play an important role in linking all the components of what is commonly referred to 
as the social brain. The social brain hypothesis may in turn be related to human feeding 
behavior; several functional MRI studies have detected a correlation between neural 
activity and eating behavior.
Magnetization transfer imaging is another sensitive MRI technique that can be used to 
evaluate changes in brain microstructure.23 Using both DTI and magnetization transfer 
imaging, Sala and colleagues21 recently showed that clustering of risk factors in MetS is 
associated with evidence of microstructural damage in the gray and white matter as 
indicated by a decreased magnetization transfer ratio histogram peak height and 
increased mean diffusivity. Voxel-wise analysis of cortical gray matter magnetization 
transfer ratio showed that changes were diffuse and symmetric in both hemispheres. 
Future longitudinal studies should determine whether these changes evolve into more 
pronounced structural deterioration or changes in cognition.
Arterial Stiffness
Pulse wave velocity (PWV) is a surrogate marker of vascular stiffness. It is defined as the 
velocity of the systolic wave front propagating through the vessels (Figure 14) with 
increased PWV, indicating arterial wall stiffening. MRI enables PWV assessment in 
different vascular territories, including the aortic arch and the carotid arteries. By using 
MRI, Roes and colleagues24 found that aortic PWV was increased in MetS subjects. 
Another study found that aortic PWV is associated with LV mass and lacunar brain 
infarcts in hypertensive patients.25 These observations may be explained by the concept 
that aortic stiffening increases exposure of the microcirculation to abnormal physical 
forces that may lead to endorgan damage.26 MRI enables a comprehensive evaluation of 
the heart, large vessels, and brain. Future studies should focus on the pathogenesis of 
end-organ damage in MetS, and evaluate the effect of interventions.
FIGURE 14. MR assessment of arterial stiffness: Pulse 
wave velocity (PWV). Through-plane velocity encoded MRI 
assessment of PWV at 1.5 T. (A) Sagittal gradient-echo 
image aligned with the long axis of the aorta shows 2 
perpendicular image acquisition planes through the 
ascending aorta and abdominal aorta. The path length is 
indicated by Δx. (B) Velocity curves are used to assess the 
time delay (Δt) of the arrival of the proximal (blue curve) 







The relationship between MetS and chronic kidney disease (CKD) has become increas-
ingly clear over the past years. Even before the onset of overt diabetes or hypertension, 
patients have an increased risk of microalbuminuria and renal insufficiency. CKD patho-
physiology involves accumulation of toxic lipids, inflammation, neurohumoral factors, and 
ultimately fibrosis.27 MR assessment of renal TG content (RTGC) was performed in 
diabetic mice, using chemical shift-selective imaging in combination with BOLD MRI. The 
results showed that RTGC was inversely correlated with intrarenal oxygenation, suggest-
ing a possible causal link between RTGC and CKD.28 Recently, it has been shown that 
human RTGC can be assessed reliably with 1H-MRS (Figure 15).29 Therefore, renal 1H-MRS 
provides a tool to study the association between RTGC, MetS, and CKD in humans. As a 
final common pathway of CKD in MetS, quantitative imaging of renal fibrosis—in parallel 
with heart and liver—with MR is an obvious next step. To this end, several methods, such 
as quantitative susceptibility mapping and renal T1 mapping, are promising.30
Pancreas
In parallel with NAFLD, fatty pancreas is associated with visceral obesity and hypertri-
glyceridemia. This was shown in a population study using iterative decomposition of water 
and fat with echo asymmetry and least squares estimation (IDEAL), which is a DIXON- 
based technique with 3 echoes to account for both B0 and B1 magnetic field inhomogene-
ities.31 Further studies are needed to clarify the role of fatty pancreas in MetS pathophysi-
ology.
Skeletal Muscle
An increased level of intramyocellular lipids, without a corresponding increase in 
extramyocellular lipids, is a key feature of peripheral insulin resistance, that may play a 
role in the increased hepatic steatosis and dyslipidemia, observed in MetS.32,33 1H-MRS is 
the only technique sensitive enough to differentiate intramyocellular lipids from 
extramyocellular lipids (Figure 16). Using 31P-MRS, skeletal muscle phosphate–ATP flux 
can be assessed, thereby providing insight into mitochondrial (dys)function and its 
relationship with insulin sensitivity.34 
SUMMARY
MR is a powerful, noninvasive tool to assess multiorgan involvement in MetS. Key 
elements of MetS pathophysiology, ranging from ectopic lipid accumulation to end-organ 
damage of liver, heart, brain, kidney, pancreas, and skeletal muscle, can be evaluated 
using a multitude of MR techniques. As such, MR has proven its utility with respect to 
unraveling MetS pathophysiology, as well as monitoring efficacy of therapeutic interven-
tions.
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To assess the feasibility of renal proton magnetic resonance spectroscopy for quantifica-
tion of triglyceride content and to compare spectral quality and reproducibility without 
and with respiratory motion compensation in vivo.
Materials and Methods:
The Institutional Review Board of our institution approved the study protocol, and written 
informed consent was obtained. After technical optimization, a total of 20 healthy volun-
teers underwent renal proton magnetic resonance spectroscopy of the renal cortex both 
without and with respiratory motion compensation and volume tracking. After the first 
session the subjects were repositioned and the protocol was repeated to assess repro-
ducibility. Spectral quality (linewidth of the water signal) and triglyceride content were 
quantified. Bland-Altman analyses and a test by Pitman were performed.
Results:
Linewidth changed from 11.5±0.4 Hz to 10.7±0.4 Hz (all data pooled, p  0.05), without and 
with respiratory motion compensation respectively. Mean % triglyceride content in the 
first and second session without respiratory motion compensation were respectively 
0.58±0.12% and 0.51±0.14% (P = NS). Mean % triglyceride content in the first and second 
session with respiratory motion compensation were respectively 0.44±0.10% and 
0.43±0.10% (P = NS between sessions and P = NS compared to measurements with 
respiratory motion compensation). Bland-Altman analyses showed narrower limits of 
agreement and a significant difference in the correlated variances (correlation of −0.59, 
P  0.05).
Conclusion:
Metabolic imaging of the human kidney using renal proton magnetic resonance spectros-
copy is a feasible tool to assess cortical triglyceride content in humans in vivo and the use 
of respiratory motion compensation significantly improves spectral quality and reproduc-
ibility. Therefore, respiratory motion compensation seems a necessity for metabolic 
imaging of renal triglyceride content in vivo.
METABOLIC IMAGING OF HUMAN KIDNEY TRIGLYCERIDE 
CONTENT: REPRODUCIBILITY OF PROTON MAGNETIC RESONANCE 
SPECTROSCOPY
Adapted from PLOS ONE. 2013 Apr 19;8(4).
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INTRODUCTION
The global increase in chronic kidney disease (CKD) parallels the obesity epidemic. 1 
Obese subjects have a weight-dependent 2- to 7-fold increased risk in progression of CKD 
irrespective of the underlying cause.2,3 Surprisingly, little is known on how obesity can 
progress or even lead to renal disease. Obesity is associated with a secondary form of 
focal segmental glomerulosclerosis, coined obesity-related glomerulopathy (ORG) when 
no other primary renal disease appears present. A recent study found a ten-fold 
increased incidence of ORG in native kidney biopsies between 1986–2000, suggesting a 
newly emerging epidemic.4 Accumulating evidence from experimental and scarce limited 
human biopsy studies link ectopic lipid deposition in the kidney (renal adiposity or fatty 
kidney) to the development of ORG.5–8 Unfortunately, clinical research on renal adiposity is 
hampered by the fact that it is considered unethical to biopsy human kidneys (repeatedly) 
without clear evidence of (late) renal disease.
Proton magnetic resonance spectroscopy (1H-MRS) is a tool for metabolic imaging to 
non-invasively assess triglyceride (TG) content in different human tissues in vivo, includ-
ing the heart, liver and skeletal muscle.9,10 Spectral quality and reproducibility of e.g. 
cardiac 1H-MRS are influenced by respiratory motion.11 Compensation for respiratory 
motion using navigator gating and volume tracking improves myocardial spectral quality 
and reproducibility.11,12 However, 1H-MRS for detection of renal TG content has never been 
performed to our knowledge. Furthermore, the possible effects of respiratory motion on 
reproducibility are unknown.
The purpose of this study was to assess the feasibility of renal 1H-MRS and to compare 
spectral quality and reproducibility without and with respiratory motion compensation in 
vivo. The results show that 1H-MRS is a feasible tool to assess cortical TG content in 
humans in vivo and use of respiratory motion compensation with navigator echoes 






The Institutional Review Board of our institution (Leiden University Medical Center) 
approved the study protocol, and written informed consent was obtained from all partici-
pants. The research was conducted according to the principles expressed in the Declara-
tion of Helsinki.
Study design
A total of 37 healthy volunteers without a history of renal or cardiovascular disease, were 
prospectively included in the study. 1H-MRS of the renal cortex was performed at rest. 
1H-MRS with and without respiratory motion compensation and volume tracking was 
performed during one session with the same parameters, without changing the position 
of the voxel. Thereafter, the volunteer was removed from the scanner. The volunteer was 
repositioned in the scanner and planning and 1H-MRS was repeated with and without 
respiratory navigator gating and volume tracking. The coil position was not marked.
MR Technique
Measurements were performed at 1.5 T (Gyroscan ACS/NT15; Philips, Best, the Nether-
lands) using a 17 cm diameter circular surface coil, centered at the level of the left kidney. 
Scout images of the left kidney were made in a coronal, sagittal and axial orientation to 
verify coil position, Figure 1 (single-shot TSE sequence, shortest TR, TE = 80 ms, slice 
thickness =3 mm, no gap).
1H-MR Spectroscopic Technique
Renal 1H-MR spectra were obtained from the cortex of the left kidney. The built-in body 
coil was used for RF transmission and the surface coil was used for signal reception. A 4 
ml voxel (40x10x10 mm3 [height x length x width]) was positioned in the cortex on the 
scout images avoiding contamination from perirenal and renal sinus fat (Figure 1). In a 
subset of volunteers spectra with deliberate voxel misplacement with localization in the 
renal sinus were also measured. A point resolved spectroscopy sequence was used to 
acquire single voxel MR spectroscopic data. Per acquisition 1024 data points were 
acquired using 1000 Hz spectral bandwidth and averaged over 64 acquisitions. A TR of 
3000 ms was chosen to approach complete relaxation of the TG signals. For respiratory 
motion compensation a pencil beam navigator was positioned on the right hemi-dia-
phragm.12–14 A two-dimensional spatially selective RF pulse for pencil beam-shaped 
excitation was used. A pencil beam of 25 mm diameter was selected. Respiratory naviga-
tor gated spectroscopic data were accepted during in a predefined acceptance window of 
5 mm diaphragm displacement in end-expiration. Residual motion was compensated with 
motion tracking.
Preparation phases, including F0 determination, gradient shimming and water suppres-
sion were performed using respiratory motion compensation. To generate an internal 
reference, a spectrum without water suppression with a repetition time of 10 s and 4 
averages was obtained, without changing any other parameter. Total acquisition time for 
both a water suppressed and water unsuppressed spectrum, including (re)positioning of 
the patient, shimming, and parameter adjustment for water suppression, was on average 
20 min.
Spectral Quantification
1H-MR spectroscopic data were fitted in the time domain, directly on free-induction 
decays using Java-based MR user interface software (jMRUI version 4.0; developed by A. 
van den Boogaart, Katholieke Universiteit Leuven, Leuven, Belgium).15 Data were analyzed 
within consensus by two authors with 7 (S.H.) and 20 (H.L) years of experience. The 
Hankel-Lanczos filter (single-variable decomposition method) was used to remove 
residual water signal from spectra acquired with water suppression. Renal cortical TG 
signal amplitudes were analyzed automatically by using the frequency estimates for renal 
lipids, described with the assumption of Gaussian line shapes at 0.9, 1.3, and 2.1 ppm. 
Prior knowledge was incorporated into the fitting.16–18 Fixed frequencies for TG peaks were 
used, line widths and amplitudes were unconstrained. The zero-order phase correction 
was estimated by using the AMARES algorithm. The water signal peak at 4.7 ppm was 
quantified and its linewidth was estimated by using a Lorentzian line shape in the AMA-
RES algorithm. The percentage of myocardial TG relative to water (%TG) was calculated 
as area under TG peak/area under water peak x 100. Spectral quality was quantified as 
the full width at half maximum (FWHM) of the water resonance in the unsuppressed 
spectra with, and without respiratory motion compensation.
Statistical Analysis
FWHM was quantified using a paired T-Test for all data pooled (linewidth). Mean coeffi-
cients of variations for both ungated and gated measurements were quantified separately. 
To compare reproducibility of renal %TG with and without respiratory navigator gating and 
volume tracking, the intra-class correlation coefficients (ICC, two-way mixed, absolute 
agreement) were calculated by using a mixed effects ANOVA (with patients as random 
factor) for both conditions separately. Moreover, Bland- Altman plots were constructed. A 
test by Pitman was performed to analyze whether the correlated variances of the two 
techniques differed.19 P  0.05 was considered significant. Means ± standard errors (SE) 
are displayed. Statistical analyses were performed by using SPSS, version 20.01.
FIGURE 1. Planning of the proton magnetic resonance 
spectroscopy voxel. Placement of the proton magnetic 
resonance spectroscopy (1H-MRS) voxel (40x10x10 mm), 
avoiding contamination with intra-abdominal/perirenal 
and renal sinus fat. Coronal (A), sagittal (B) and transverse 







Since the start of the technique developmental phase, 1H-MRS of the kidney was per-
formed prospectively in 37 consecutive healthy volunteers without a history of renal or 
cardiovascular disease. A total of 17 volunteers were excluded from analyses during this 
initial phase: A) due to technical optimization and time constraints the scanning could not 
be completed [9 subjects], B) erroneous navigator [2 subjects] and C) impossible fitting 
procedure of all acquired spectra [6 subjects]). Based on these initial scans, the optimal 
technical protocol was defined.
In 20 volunteers the complete scanning protocol was completed (12 males, mean age ± SD 
26.3 ± 8.3 yrs, range 20.3 – 57.9 yrs). In 4 of these volunteers the spectra acquired without 
respiratory motion compensation were not used for analysis, due to their degraded 
quality.
The linewidth of the unsuppressed water signal changed from 11.5 ± 0.4 Hz to 10.7 ± 0.4 
Hz (all data pooled, p  0.05), without and with respiratory navigator gating respectively.
A typical example of a 1H-MR spectrum of renal cortical TG content is shown in Figure 2. 
An example of a spectrum obtained in the region of the renal sinus shows an expectedly 
high percentage of TG content (Figure 3).
FIGURE 3. Examples of spectra including the renal parenchyma and 
sinus, and including only the renal parenchyma. Unsuppressed localized 
renal proton spectra of triglyceride (TG) content with deliberate plan-
ning of the voxel including the renal sinus (in green) and including only 
the renal parenchyma (in red). Percentages TG content in this particular 
volunteer were 18% (renal sinus) and 0.64% (parenchyma). doi:10.1371/
journal.pone.0062209.g003
FIGURE 4. Reproducibility plots of renal triglyceride 
content. Bland-Altman plots of renal cortical triglyceride 
(TG) content calculated from spectra without (n = 16, A) the 
use of the respiratory navigator, and with (n = 20, B) the 
use of the respiratory navigator showing narrower limits 
of agreement/improved reproducibility. doi:10.1371/
journal.pone.0062209.g004
FIGURE 2. Planning of the respiratory navigator. The 
navigator pencil beam is positioned on the right hemi 
diaphragm (panel A). Panel B shows the calibration phase 
with a high temporal resolution, in which the lung-liver 
interface is detected during free breathing, as well as the 
acquisition phase showing the accepted measurements in 
the predefined end-expiratory window (lower temporal 
resolution). Panel C shows a typical non-suppressed (left) 
and a suppressed (right) localized renal proton spectrum, 





Mean %TG in the first and second session without the use of the respiratory navigator 
were respectively 0.58 ± 0.12% and 0.51 ± 0.14% (P= NS). Mean %TG in the first and second 
session with respiratory navigator gating were respectively 0.44 ± 0.10% and 0.43 ± 0.10%. 
(P=NS between sessions and P= NS compared to respiratory gated measurements). One 
volunteer showed higher TG content compared to all others (2.1 and 2.2% with the use of 
respiratory motion compensation and without motion compensation respectively), albeit 
no technical explanation could be found (e.g. erroneous planning or navigator dysfunc-
tion).
Coefficient of variation without the use of the navigator was 42% which improved to 27% 
with use of respiratory motion compensation. ICC without the use of the respiratory 
navigator was 0.79 (95% confidence interval 0.51–0.92, P  0.001) and improved to 0.92 
(95% confidence interval 0.81–0.97, P  0.001) with the use of respiratory motion compen-
sation. Moreover, Bland-Altman plots (Figure 4) showed narrower limits of agreements 
with the use of the respiratory navigator, with a significant improvement in variability with 
the use of the respiratory navigator compared to ungated measurements, Pearson 
correlation (derived from the test by Pitman) of −0.59, P  0.05.
DISCUSSION
The present study shows that metabolic imaging of the human kidney for detection of 
cortical TG content using 1H-MRS is feasible. Respiratory motion compensation improves 
spectral quality and measurement reproducibility.
Intracellular lipid accumulation causing lipotoxicity in humans with the metabolic 
syndrome or type-2 diabetes mellitus, as assessed with 1H-MRS, has been associated 
with organ dysfunction, such as non-alcoholic fatty liver disease,20 cardiac diastolic 
dysfunction 9,21 and pancreatic beta cell dysfunction.22,23 Moreover, respiratory motion 
compensation techniques to assess these lipid pools have been used in 1H-MRS previ-
ously, including the heart and pancreas.11,24,25 The mean percentage of renal TG content in 
the present study content is in line with previous, Dixon-based techniques.26
The ratio of TG and water show values which are comparable to the quantified amounts of 
TG found in the human heart.11 However, one subject showed a consistently higher 
percentage, which could not be attributed to technical failure, physical activity or nutri-
tional status. Moreover, this volunteer was not different from other subjects in terms of 
age. In contrast, deliberate planning of the voxel in the region of the renal sinus in a 
subset of volunteers showed clear overestimation, with TG values ranging from 8 to 25 
percent. We can therefore not exclude a relatively wide range in physiological TG content 
in humans. Future studies on the effects of age, gender differences and the relation of 
renal cortical TG content with parameters of renal function or proteinuria should address 
this variability in TG content. A recent study indeed showed an age related increase in 
renal lipid content in mice, associated with increased glomerulosclerosis,27 as well as an 
increase after a high-fat diet.28 Moreover, high-fat diet induced renal steatosis is reversed 
with the use of a peroxisome proliferator-activated alpha agonist (which regulates renal 
lipolysis) in mice, with associated improvements in albuminuria and fibrosis.29 In addition 
to the PPAR-gamma pathway, the reninangiotensin aldosteron system activation has also 
been linked to renal adipogenesis. Lisinopril, an ACE-inhibitor, caused normalization of 
renal adipogenesis and diminished lipid accumulation in uninephrectomized rats.30 
Moreover, it was shown in pigs with the metabolic syndrome that renal adiposity was 
associated with glomerular hyperfiltration and microvascular proliferation.6 These 
animal studies suggest that renal adipogenesis is linked to critical pathways in obesi-
ty-associated renal disease with possibilities for intervention. However, data in humans is 
scarce. In humans renal sinus fat is associated with intra-abdominal and retroperitoneal 
fat content and with control of hypertension.31
During respiration, movement of the diaphragm causes a displacement of the kidney 
relative to the spectroscopic voxel. Respiration may thereby influence spectral accuracy 
and reproducibility by influencing shimming, water suppression as well as varying partial 
volume changes in fat fraction. To overcome these problems, respiratory motion compen-
sation has been used before to improve 1H-MRS spectral quality. For example by using 
triggering on exhalation,32 or with breath-hold acquisition.33 Both studies were not 
primarily designed for detection and reproducibility of renal TG content. However, one 
study reports variations in lipid content as a consequence of contamination with lipids 
from outside the region of interest during free breathing. The present results are in line 
with these findings, as spectral quality and reproducibility of renal TG stores improved 
with respiratory motion compensation. Moreover, all spectra obtained with respiratory 
motion compensation could be accurately fitted, whereas 4 of the spectra obtained 
without respiratory motion compensation were of insufficient quality, due to poor water 
suppression or ghosting signals. 
The improvements in spectral quality in terms of linewidth are in line with previous 
reported values for cardiac and skeletal muscle spectroscopy.11,34
Moreover, the use of the respiratory navigator improved the coefficient of variation and 
showed narrower limits of agreement in Bland-Altman analyses. However, the resulting 
coefficient of variation of 27% remains relatively high. We hypothesize this may be due to 
local inhomogeneities in renal parenchymal TG content, or variations in cortical and 
medullar TG content contribution within the voxel, as the voxel is close to the renal 
medulla and TG content may be distributed differentially.35,36 Nevertheless, reproducibil-
ity improved with respiratory motion compensation and seems necessary for human in 
vivo TG quantification. 
A limitation of our study may be that 1H-MR spectra were obtained in one position in a 
single kidney only. Future studies should focus on possible regional differences in lipid 
content, possible differences in position in the cortex or medulla and the relationship with 
parameters of the metabolic syndrome, such as abdominal fat content, liver fat content 
and clinical parameters such as body mass index, serum TG content, cholesterol as well 
as renal function and proteinuria.
CONCLUSIONS
Metabolic imaging of the human kidney using 1H-MRS is a feasible tool to assess cortical 
TG content in humans in vivo and the use of respiratory motion compensation with 
navigator echoes significantly improves spectral quality and reproducibility. Therefore, 
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Obesity and type 2 diabetes have not only been linked to fatty liver, but also to fatty kidney 
and chronic kidney disease. Since non-invasive tools are lacking to study fatty kidney in 
clinical studies, we explored agreement between proton magnetic resonance spectros-
copy (1H-MRS) and enzymatic assessment of renal triglyceride content (without and with 
dietary intervention). We further studied the correlation between fatty kidney and fatty 
liver.
Methods
Triglyceride content in the renal cortex was measured by 1H-MRS on a 7-Tesla scanner in 
27 pigs, among which 15 minipigs had been randomized to a 7-month control diet, 
cafeteria diet (CAF) or CAF with low-dose streptozocin (CAF-S) to induce insulin-indepen-
dent diabetes. Renal biopsies were taken from corresponding MRS-voxel locations. 
Additionally, liver biopsies were taken and triglyceride content in all biopsies was mea-
sured by enzymatic assay.
Results
Renal triglyceride content measured by 1H-MRS and enzymatic assay correlated positively 
(r = 0.86, P  0.0001). Compared with control diet-fed minipigs, renal triglyceride content 
was higher in CAF-S-fed minipigs (137 ± 51nmol/mg protein, mean ± standard error of the 
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mean, P  0.05), but not in CAF-fed minipigs (60 ± 10nmol/mg protein) compared with 
controls (40 ± 6 nmol/mg protein). Triglyceride contents in liver and kidney biopsies were 
strongly correlated (r = 0.97, P  0.001).
Conclusions
Non-invasive measurement of renal triglyceride content by 1H-MRS closely predicts 
triglyceride content as measured enzymatically in biopsies, and fatty kidney appears to 
develop parallel to fatty liver. 1H-MRS may be a valuable tool to explore the role of fatty 





Over the past decades, the prevalence of obesity and type 2 diabetes has grown to 
epidemic proportions.1 Obesity, in particular central obesity, is associated with metabolic 
dysfunction, which drives the development of insulin resistance leading to type 2 diabetes 
and ultimately end organ damage. The combination of obesity and type 2 diabetes, also 
referred to as diabesity, is often accompanied by other cardiovascular risk factors, 
including hypertension and dyslipidaemia. Common early markers of renal disease like 
glomerular hyperfiltration and increased urinary albumin are more prevalent in both 
obesity and type 2 diabetes.2 Furthermore, renal pathology has shown considerable 
overlap between obesity and type 2 diabetes.3
How (early) diabesity may lead to incipient chronic kidney disease remains to be under-
stood, but ectopic lipid accumulation in the kidney (fatty kidney) has gained appreciation 
as a novel potential pathway.2, 4–6 Diabesity is associated with lipid accumulation in 
non-adipose tissue such as liver, skeletal muscle and heart, and this so-called ectopic fat 
may interfere with cellular function in the respective organ.7–10 Notably, obesity and type 2 
diabetes have been associated with renal lipid accumulation in both human and porcine 
kidneys with differences in anatomical distribution between glomeruli and tubuli, as well 
as cortex and medulla.11, 12 Increased renal lipid content has also been linked to functional 
and structural renal hyperfiltration12, obesity-related glomerulopathy2 and type 2 diabetic 
nephropathy13. Various rodent models have shown that intervention in cellular lipid 
pathways attenuated obesity-related glomerulopathy or diet-induced chronic kidney 
disease.14 To date, translation of such experimental evidence to the clinical arena has 
been hampered by lack of a non-invasive diagnostic tool to sequentially monitor renal 
lipid accumulation in obesity and type 2 diabetes mellitus.
Proton magnetic resonance spectroscopy (1H-MRS) is a non-invasive and reproducible 
technique that has been used successfully to quantify lipid content in heart, liver and 
muscle.15–17 Recently, feasibility and reproducibility of renal 1H-MRS in vivo was shown.18 
However, few 1H-MRS protocols have been validated against tissue biopsies.
Therefore, we explored the agreement of the non-invasive 1H-MRS renal triglyceride 
measurement, using a 7-Tesla magnetic resonance (MR) scanner, against a biochemical 
assay (as gold standard) to determine lipid accumulation in of porcine kidneys. Secondly, 
we measured renal triglyceride content after a dietary intervention study in minipigs. We 
investigated the effects of a high-fat, high-cholesterol cafeteria diet without (CAF) and 
with low-dose streptozocin (STZ) (CAF-S) to induce non-insulin-dependent diabetes 




Fourteen left-sided porcine kidneys were harvested from two Dutch pig slaughter lines. 
The kidneys were harvested within 30 min of termination to limit warm ischaemia time 
and were placed on ice. Kidneys were flushed with University of Wisconsin (UW) fluid and 
were scanned upon arrival. Tissue biopsies were taken from both the upper and lower 
pole of each kidney, immediately after scanning. The biopsy locations were visually 
matched to the areas where the 1H-MRS measurements were performed. Biopsies were 
snap-frozen in liquid nitrogen and stored at -80°C.
Group B 
A total of 15 Göttingen minipigs19 were studied after they had been randomized to two 
different diets. The control group received a diet consisting primarily of barley, wheat and 
soya bean oil. The CAF group was fed a cafetaria diet20, with a high content of lard, 
fructose, sucrose and added cholesterol. Five of the CAF-fed pigs were additionally 
treated with STZ after 5 months. The dose of STZ was individually adjusted to induce 
non-insulin-dependent diabetes to model type 2 diabetes. After 7 months of diet, the pigs 
were euthanized. Directly after termination, blood was drawn and a liver biopsy was 
taken. The whole study was executed at Ecole Veterinaire D’Alfort, France, and was 
approved by the local ethics committee for animal experiments. The same harvesting and 
analyses protocols performed for Group A were followed: left-sided kidneys were 
harvested with a maximum of 30 min warm ischaemia time, kidneys were flushed with 
UW fluid and transported to the hospital in the Netherlands on ice, for subsequent 7-Tesla 
MR scanning. After each MR scan, renal biopsies were taken from the corresponding 
MRS-voxel location of the upper and lower kidney poles. Biopsies were snap-frozen and 
stored at -80°C. For both Groups A and B, all kidneys had a maximum cold ischaemia time 
of 20 h before 1H-MRS was performed.
Measurements
Proton Magnetic Resonance Spectroscopy
A 7-Tesla Philips Magnetic Resonance Imaging (MRI) scanner (Philips Healthcare, Best, 
The Netherlands) was used to measure renal triglyceride content by 1H-MRS. A Nova 
quadrature transmit and 32-channel receive head coil (Nova Medical, Wilmington, MA, 
USA) was used for transmission and reception. A survey together with a Dixon water-fat 
scan was performed to position the MRS voxel (10 x 10 x 10mm3) within the cortex of the 
kidney trying to avoid the medulla as much as possible.21 On the Dixon scan fat image 
(Figure 1B) correct placement was confirmed, carefully avoiding extracellular (sinus or 
perirenal) lipids in the voxel. Secondly, measurements were performed in the upper and 
lower pole of each kidney. Stimulated echo acquisition mode (STEAM) spectra were 
acquired with an echo time of 8.2 ms without water suppression [repetition time (TR) 9 s, 
3 averages] and with Multiply Optimized Insensitive Suppression Train (MOIST) water 
suppression (TR 3.5 s, 96 averages).22, 23 The MRS acquisition had a bandwidth of 3000 Hz 
and 4096 samples were acquired resulting in a spectral resolution of 0.73 Hz/sample. All 
spectra were fitted in the time-domain using the Java-based MR User Interface (jMRUI).24 
The advanced method for accurate, robust and efficient spectral fitting (AMARES) 
algorithm was used to fit the resonances to a Gaussian line shape. Triglyceride content 
was calculated as a percentage of the (unsuppressed) water peak using the following 
equation:
where, TG = renal triglyceride content (%), TG methyl = area of the methyl resonance at 
0.9 ppm (arbitrary unit), TG methylene = area of the methylene resonance at 1.3 ppm 
(arbitrary unit), Water = area of the water resonance (arbitrary unit).
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kidney. Stimulated echo acquisition mode (STEAM) spectra were acquired with an echo time 
of 8.2 ms without water suppressi n [repetition time (TR) 9 s, 3 averages] and with Multiply 
Optimized Insensitive Suppression Train (MOIST) water suppression (TR 3.5 s, 96 
averages) [22, 23]. The MRS acquisition had a bandwidth of 3000 Hz and 4096 samples 
were acquired resulting in a spectral resolution of 0.73 Hz/sample. All spectra were fitted in 
the time-domain using the Java-based MR User Interface (jMRUI) [24]. The advanced 
method for accurate, robust and efficient spectral fitting (AMARES) algorithm was used to fit 
the reson nces to a Gaussian line shape. Triglyceride content was calculated as a 
percentag  of the (unsuppressed) water peak using the following equation:
=
 ℎ  ( 3) +  ℎ  ( 2 )
+  ℎ  ( 3) +  ℎ  ( 2 )
× 100%      (1)
where, TG = renal triglyceride content (%), TG methyl = area of the methyl resonance at 0.9 
ppm (arbitrary unit), TG methylene = area of the methylene resonance at 1.3 ppm (arbitrary




Enzymatic measurement of lipids in renal and liver biopsy
The biopsies from the upper and lower pole of each kidney, as well as the liver biopsies, 
were snap-frozen in liquid nitrogen, homogenized and total lipids were extracted accord-
ing to a modified protocol from Bligh and Dyer.25 Total triglycerides were measured by an 
enzymatic kit (no. 11488872, Roche Diagnostics, Rotkreuz ZG, Switzerland). The triglycer-
ide content per biopsy was divided by the protein content (nmol triglycerides/mg protein) 
to correct for the size of the biopsy.
Oil-red-O staining
Frozen kidney sections (10 µm thickness) were cut on a Reichert cryostat microtome. Oil 
Red O (ORO) staining was performed by incubation of the slides with an ORO solution (2 
mg/mL in 40% isopropanol). Sections were rinsed with ethanol, covered with Aqua-Mount 
mounting media and digitized with a Philips Ultra-Fast 1.6 RA Scanner (Philips, Best, The 
Netherlands). The ORO-positive surface area was measured using ImageJ (US National 
Institutes of Health, Bethesda, MD, USA) on five random selected areas of the renal 
cortex, and the percentage of the positive area was calculated.
Other laboratory measurements
Concentrations of plasma triglycerides and creatinine [both total coefficient of variation 
(CV): 1.0–1.2%, determined by vendor], urinary creatinine (total CV: 0.5–0.7%) and urinary 
protein (total CV: 0.2–0.6%) were measured on a Modular P800 analyser (Roche, Basel, 
Switzerland). Plasma fructosamine (total CV: 1.2–1.5%) was measured using a Cobas 6000 
analyser (Roche). 
Statistics
All statistical analyses were performed using SPSS version 22.0 (IBM SPSS Statistics for 
Windows, IBM Corp., Armonk, NY, USA). Plots were created using Graph Pad (Graph Pad 
Software, La Jolla, CA, USA). All but one analysis were performed with the average 
triglyceride content from the upper and lower pole of each kidney. Bland–Altman analysis 
was performed to evaluate the agreement between renal triglyceride content by 1H-MRS 
and renal lipid content by enzymatic essay, after normalization of the data. In one case, 
the triglyceride content of a single pole was taken due to a corrupt MRS data file. Agree-
ment between the triglyceride measurement techniques was evaluated by linear regres-
sion with a 95% prediction interval. Group differences between the three experimental 
groups were analysed using analysis of variance (ANOVA). Least significant difference 
(LSD) post hoc tests were used in case of a significant difference. Non-normally distrib-
uted data were log-transformed and checked for normality after transformation. Data are 
expressed as mean values ± standard error of the mean (SEM) and a probability value of 
 0.05 was considered statistically significant.
FIGURE 1: Placement of the voxel (black box) in the kidney 
cortex on a transverse and coronal survey (A) and Dixon 
fat image (B). Below the surveys are two spectra (C) 
acquired from the kidney cortex of two different kidneys. 
Spectra have been selected to show an example of low and 
high renal triglyceride (TG) content and have been scaled 
to the water signal to be able to visually compare the two. 
For quantification of TG content the (CH2)
n (1.3 ppm) and the 
CH3 (0.9 ppm) resonances are used. Other visible reso-
nances in the spectra are CH2CH2COO marked with number 
1 at 1.5 ppm, CHCH2 = CHCH2 marked with number 2 at 2 
ppm and CH2COO marked with number 3 at 2.2 ppm, and a 





Validation of renal triglyceride quantification by 1H-MRS
Renal triglyceride content was measured in 29 left-sided porcine kidneys by 1H-MRS and 
by enzymatic assay. Two measurements had to be excluded from further analysis due to a 
failed measurement in the enzymatic assay and one due to a corrupt MRS data file, 
resulting in a total of 27 measurements (n = 12 from Group A, n = 15 from Group B).
In Group A (slaughter pigs), the mean renal triglyceride content was 0.23 ± 0.03% (mean ± 
SEM) as measured by 1H-MRS and 111 ± 15 nmol/mg protein as measured by enzymatic 
assay. The mean renal triglyceride content in Group B (minipigs) was 0.15 ± 0.03% as 
measured by 1H-MRS and 79 ± 20 nmol/mg protein as quantified by enzymatic assay.
Data from Groups A and B were pooled and triglyceride content measured by 1H-MRS and 
enzymatic assay showed a positive correlation (r = 0.86, P  0.0001, Figure 2). The regres-
sion equation was as follows: triglycerides measured by 1H-MRS (%) = 0.03 + 0.0017 × 
triglycerides measured by enzymatic assay (nmol/mg). The triglyceride content for the 
pooled data ranged from 0.06% to 0.8% as measured by 1H-MRS and from 30 to 331 nmol/
mg protein as measured by enzymatic assay.
The Bland–Altman analysis using the normalized data showed good agreement with a 
bias of 0.00 (limits of agreement -0.8; 0.8) for 1H-MRS and enzymatic essay measure-
ments of renal lipid content over the metabolic spectrum (Figure 2B).
MR spectroscopy showed a similar trend between the groups, however, this was not 
statistically significant.
Similarly, hepatic triglyceride content after the 7-month diet was higher in the CAF-S 
group (417 ± 157 nmol/mg protein) compared with the control group (67 ± 11nmol/mg 
protein, P  0.05). The CAF group (141 ± 49nmol/mg protein) had a trend towards higher 
hepatic triglyceride content than the control group, but this was not significantly different 
(Figure 3). We observed a significant correlation between renal and hepatic triglyceride 
content measured by enzymatic assay (n = 14, r = 0.97, P  0.001, Figure 4). 
FIGURE 2: Correlation (left) and Bland–Altman difference–
average plot (right) of renal triglyceride (TG) content 
measured by 1H-MRS and enzymatic assay in biopsies, 
using pooled data from both Group A (A) (12 slaughter pigs) 
and Group B (B) (15 minipigs) showing a positive correla-
tion (R=0.86, P  0.0001).
Effects of CAF and STZ
The minipigs were 2.7 ± 0.2 years of age at termination. The pigs in the control group were 
heavier at the start of the study (62.7 ± 3.3 kg, P  0.05) than the pigs in the CAF group (51.4 
± 2.0 kg) and CAF-S group (49.7 ± 2.8 kg). The 7-month CAF induced a significantly larger 
weight gain (39.6 ± 3.6 kg) than the control diet (23.4 ± 3.1 kg, P  0.05) and the CAF-S diet 
(23.2 ± 5.5 kg, P  0.05, Figure 3). Serum fructosamine was higher in the CAF-S group (358 
± 31 mmol/L, P  0.05), than in the CAF (264 ± 6 mmol/L) and control groups (259 ± 11 
mol/L). Serum triglycerides, serum creatinine and urine protein did not significantly differ 
between the groups.
Renal triglyceride content was higher in the CAF-S group (137 ± 51 nmol/mg protein) 
compared with the control group (40 ± 6 nmol/mg protein, P  0.05) (Figure 3). Renal 
triglyceride content in the CAF group (60 ± 10 nmol/mg protein) was not significantly 
different from the control group (Figure 3). Renal triglyceride content measured by proton 
FIGURE 3: Weight gain (A), renal triglyceride (TG) content 
measured by proton magnetic resonance spectroscopy 
(1H-MRS, B), renal TG content from renal biopsy by enzy-
matic assay (C) and hepatic TG content from liver biopsy by 
enzymatic assay (D) after 7 months of control diet, CAF or 
CAF-S. Data are presented as mean ± SEM (n = 15 for renal 
triglycerides, n = 14 for hepatic triglycerides). *P  0.05.
FIGURE 4: Correlation between renal and hepatic 
triglyceride (TG) content after 7 months of diet, 





We also assessed lipid localization by ORO staining. The lipid content was very low in 
biopsies of the control diet group (percentage staining: 0.2 ± 0.0%), and markedly higher 
in those of the CAF group (3.7 ± 1.9%, P  0.05 versus control diet) and CAF-S group (9.6 ± 
6.3%, P  0.05 versus control diet). There was pronounced lipid accumulation in the tubuli 
and to a lesser extent ORO staining was visible in the glomeruli (Figure 5).
DISCUSSION
The merit of clinical 1H-MRS to investigate the role of ectopic lipid accumulation has been 
clearly established for other organs such as liver, muscle and heart.17, 26, 27 In fact, the 
development of 1H-MRS of the heart has led to a better understanding of factors influenc-
ing myocardial triglyceride accumulation in relation to cardiac function in both health and 
diabesity.9, 17 Our present study is one of the first to explore 1H-MRS as a non-invasive tool 
to study fatty kidney in diabesity and to study agreement with tissue biopsies.
Thus far, only few studies have reported on 1H-MRS of the kidney, most likely owing to the 
technical difficulties of developing and applying this technique reliably to the kidney for 
several reasons. Firstly, adjustment for respiratory motion and carefully avoiding 
contamination by perirenal and sinus fat is necessary to obtain reliable measurements 
from the kidney cortex only, and not surrounding structures. Secondly, kidney tissue is 
not homogenous with substantial anatomical and functional variation between cortex and 
medulla as well as glomeruli and tubuli. Lastly, due to the limited space in the kidney 
cortex, the volume of the measured voxel has to be small, resulting in a much lower 
signal-to-noise-ratio compared with e.g. heart and liver.
This notwithstanding, we previously reported a feasibility and reproducibility study of 
renal 1H-MRS in healthy (non-obese) volunteers in vivo, but variation was apparent even in 
this relative homogenous group of subjects.18 Consequently, we aimed to improve our 
knowledge on triglyceride distribution across the metabolic spectrum of diabesity and 
across kidney anatomy with regard to voxel placement and data acquisition. Also, few 
spectroscopy protocols underwent validation and testing against invasive, gold standard 
assessment of triglycerides. Because of the impossibility of obtaining enough discarded 
kidneys from obese and type 2 diabetic post mortem kidney donors to perform a valida-
tion study (those kidneys are often not offered for transplantation), we turned to simi-
lar-sized porcine kidneys to test our clinical 1H-MRS protocol. This study in porcine 
kidneys shows that 1H-MRS closely predicts the triglyceride content as measured by 
enzymatic assay of kidney biopsies (gold standard) and, therefore, it may also be a 
valuable tool to study fatty kidney in humans.
To evaluate the renal triglyceride content over the metabolic spectrum in conjunction with 
the hepatic triglyceride content, we used minipigs fed a high fat, high cholesterol diet to 
develop a metabolic syndrome phenotype including high amounts of visceral fat and 
insulin resistance.19 Because those pigs have a large pancreatic beta cell capacity, it takes 
a very long time to develop type 2 diabetes. Therefore, the pigs were individually treated 
with a low dose of STZ to damage a part of the pancreatic beta cell capacity, to create 
non-insulin-dependent diabetes that reflects type 2 diabetes. Using this model, we 
showed that renal triglyceride content increased over the metabolic spectrum in conjunc-
tion with hepatic triglycerides.
We observed a trend to an increase in both renal and hepatic triglyceride content in the 
CAF-only group, however this was not significant. Previous studies have shown correla-
tion between increased bodyweight and increased hepatic and renal triglyceride content 
in both animals and humans11, 12, 28, 29 As our study was exploratory and the animal groups 
small, the study may have been underpowered to detect a significant difference between 
the control and CAF group. One possible confounder in this study is the difference in 
baseline weight of the minipigs, as controls were significantly heavier than the pigs in the 
intervention groups.
FIGURE 5: Three representative examples of ORO staining 
for lipids in kidney biopsies from minipigs on a 7 months 
control (A), CAF (B) or CAF-S (C) diet. (D) Percentage of 
biopsy with ORO staining in the three diet groups (mean ± 





Interestingly, pigs in the CAF-S group, albeit that they had a lower baseline weight and 
equal increase in body weight during the study, did have increased renal triglyceride 
content compared with the controls. In diabetes, the increase in inflammation or chronic 
kidney disease might lead to additional triglyceride redistribution into organs beyond 
mere obesity and thus accentuate the findings.2 We found a strong positive correlation 
between renal and hepatic triglyceride content. A study in mice has shown that from a 
certain bodyweight, the expandability of white adipose tissue becomes limited and fat 
starts to rapidly accumulate ectopically within e.g. the liver.29 It is likely that a similar 
mechanism may underlie renal triglyceride accumulation, which needs to be explored in 
future studies. 
By using ORO staining, we observed similar trends, with increasing triglyceride content in 
the CAF group and even more in the CAF-S group. We found that renal triglyceride 
accumulation was most prominent in renal tubuli, albeit some triglyceride staining was 
also observed in the glomeruli. This is in accordance with a recent study of human 
nephrectomies, where triglyceride droplets were predominantly found in tubular cells 
and to a lesser extent in glomeruli.11 Future studies should focus on even better under-
standing of how triglyceride accumulation may lead to chronic kidney disease in diabesity 
and whether this process can be reversed.
CONCLUSION
Non-invasive measurement of renal triglyceride content by 1H-MRS closely predicts the 
triglyceride content as measured enzymatically in biopsies. Renal triglyceride content 
increases over the metabolic spectrum of diabesity and in the current study fatty kidney 
develops in parallel with fatty liver. 1H-MRS seems suitable to explore the role of fatty 
kidney in obesity and type 2 diabetic nephropathy in humans in vivo. 
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The aim of this thesis was to develop advanced body MR techniques that can contribute to 
the knowledge of the metabolic syndrome (MetS). Such techniques are important since 
the incidence of the metabolic syndrome is reaching pandemic proportions.
In the first part of this thesis, consisting of chapters 2, 3 and 4, new techniques for body 
MR were developed. Body MR is routinely conducted using MR scanners up to 1.5 T. 
However in the recent years, a substantial number of these 1.5 T scanners have been 
replaced by high field scanners (  3 T). The main drive to switch to higher field scanners is 
that the higher magnetic field will result in a larger effective magnetization of the spins, 
thereby increasing the signal-to-noise ratio (SNR). Nevertheless, in body MR it is chal-
lenging to achieve this gain in SNR due to an increase in imaging artefacts. One of the 
causes for these artefacts is that due to decreasing wavelength of the RF signal resulting 
in constructive and deconstructive interference, it is more difficult to create a homogene-
ous transmit field. In chapter two, (Increasing Signal Homogeneity and Image Quality in 
Abdominal Imaging at 3 T with Very High Permittivity Materials) we addressed this 
problem by applying high dielectric pads which significantly reduce the coefficient of 
variance creating a more uniform transmit field for abdominal imaging using a 3 T MR 
scanner. Furthermore, the high dielectric pads decreased average power, thereby 
reducing the global specific absorption rate (SAR). This was the case for both the quadra-
ture driven and the RF shimmed 3 T birdcage coil.
In chapter three, a similar approach (Improved Cardiac Proton Magnetic Resonance 
Spectroscopy at 3 T Using High Permittivity Pads) was used to increase the SNR of 
cardiac proton spectra. The pads were optimized using a finite time domain solver to 
obtain maximal RF field in the septum of the heart instead of a more homogeneous RF 
field over the whole heart region. In-vivo, the pads demonstrated an average increase in 
spectral SNR of 60%. If the SNR is high, this gain in SNR can be traded for a reduction in 
acquisition time by a factor of two and a half, addressing one of the biggest problems with 
MRS, namely the relatively long total acquisition time.
Even after optimizing the transmit field and receive sensitivity, MR spectroscopy remains 
technically challenging to perform reliably. This is partly due to the dynamic field fluctua-
tions introduced by respiratory motion, and in the case of heart, cardiac motion. Further-
more, there is an inherent low SNR of the metabolites of interest as well as a great 
dependency on the homogeneity of the static magnetic field. For cardiac MR spectroscopy 
in particular, there are no standard (clinical) protocols offered by manufacturers. Since 
there are many parameters that significantly impact the spectral quality, designing such a 
scan protocol remains challenging. In chapter four (Parameter Optimization for Repro-
ducible Cardiac 1H-MR Spectroscopy at 3 Tesla) we described how cardiac proton MR 
spectroscopy can be optimized and measured the reproducibility of these measurements. 
The optimized protocol involves a local power optimization, pencil beam B0 shimming, a 
cardiac trigger delay of 200 ms, pencil beam navigator-based respiratory compensation, 
and MOIST water suppression. Using this optimized protocol, a high intra- (Cv = 5%) and 
intersession (Cv = 6.5%) reproducibility of the myocardial triglyceride content was 
achieved.
In the second part of this thesis (chapters five, six and seven), the previously developed 
techniques were applied in clinical studies to gain additional insight in the development/
treatment of the MetS. In chapter five (MR of Multi-Organ Involvement in the Metabolic 
Syndrome), a literature review of the MetS was provided, focussing on the primary organs 
affected including the brain, skeletal muscle, pancreas, heart, liver and kidney. Crucial 
symptoms of MetS pathophysiology, ranging from ectopic lipid accumulation to end-organ 
damage can be evaluated using multiple MR techniques. Therefore, MR could be of added 
value in attempts to unravel the MetS pathophysiology as well as monitoring of therapy 
efficacy.
At present, much remains unknown as to how MetS affects the kidneys. Subsequently, 
there is a strong need for non-invasive tools to measure renal fat content. Although 
spectroscopy in the heart and liver has become the non-invasive gold standard for metab-
olite quantification, it was not yet performed in the kidneys. As with heart and liver 
measurements breathing complicates the application of spectroscopy in the kidney, but 
more importantly the limited size of the spectroscopy voxel results in low SNR. In chapter 
six (Metabolic Imaging of Human Kidney Triglyceride Content: Reproducibility of Proton 
Magnetic Resonance Spectroscopy), we demonstrated that MR spectroscopy can be 
performed in the kidney. Furthermore, we showed that pencil beam navigator respiratory 
triggering significantly improves both spectral quality and reproducibility. 
In liver and cardiac spectroscopy several studies have been performed to validate the 
technique to the criterion standard; biopsy. However, to our knowledge there has been no 
validation study performed to test the accuracy of renal MR spectroscopy. In chapter 
seven (Metabolic imaging of fatty kidney in diabesity: validation and dietary intervention), 
we validated this technique by comparing lipid measurements using renal proton MR 
spectroscopy with biopsies of porcine kidneys. The lipids measured by proton MR spec-
troscopy and the enzymatic assay (biopsy) correlated significantly (r=0.86, p  0.0001). In 
addition, the effects of dietary intervention on the renal lipids were measured. One group 
was fed a regular diet (group A), one a high lipid diet (group B) and a third group followed 
the same high lipid diet combined with a low-dose of streptozocin (group C) to induce 
insulin-independent diabetes. After the 9-month diet, the renal lipids in group C (high lipid 
diet combined with streptozocin) were significantly higher compared to group A (regular 
diet). Renal lipids were not significantly different between group B (high lipid diet) and 





PART ONE: TECHNICAL DEVELOPMENTS - HIGH FIELD BODY MR
Body MR can benefit from higher field strengths (3 T and higher) but often acquisition 
protocols cannot directly be transferred from lower field scanners since the increase in 
field strength introduces new artefacts, in addition to exacerbating the existing ones. 
Therefore, it can be challenging to achieve the theoretical improvements in image and 
spectral quality. These artefacts are to a large extent caused by the shortening of the 
wavelength of the transmit (RF) field in comparison to the size of the imaging object. The 
RF field then constructively and destructively adds causing hyper and hypointense areas 
in the image.
This problem of decreased transmit homogeneity has been addressed by MR manufactur-
ers by the introduction of multi-transmit systems. Alternatively, it has been shown that in 
neuro and cardiac imaging dielectric pads can be used to homogenize the transmit 
field.29,59 In this thesis a new application of the pads in abdominal imaging was examined. 
When using the high dielectric pads for liver imaging, the shading artefacts (caused by the 
inhomogeneous transmit field) have been reduced resulting in higher image quality. In 
particular, the high dielectric pads may be of added value in patients with ascites or 
pregnant women, where effect of such shading artefacts is the highest. Application of 
these pads could be the difference between an unusable and an useful scan for the 
radiologist. 
In this thesis, we have shown that the high dielectric materials used for passive shimming 
can also be applied in MR spectroscopy to increase the signal-to-noise ratio. When 
designing such pads for MRS, maximal transmit/receive sensitivity is a more important 
optimization parameter then transmit inhomogeneity since the MRS voxel is small in 
contrast to regular imaging. This results in pads that are of higher permittivity and 
thicker than the pads used when the main optimization parameter is the homogeneity of 
the transmit field. By applying these pads for cardiac spectroscopy, an increase of 60% in 
SNR was achieved. This effect was predominantly attributed to an increase in receive 
sensitivity. This effect will most likely also translate to spectroscopy of other organs, 
however, additional studies are needed. Furthermore, although passive radiofrequency 
shimming increases image and spectral quality, the dielectric pads have to be placed on 
the patient which is an extra step that limits implementation feasibility in the clinic. 
Moreover, correct placement of the dielectric pads requires the MR operator to have a 
basic knowledge about the methodology of the pads. A potential solution to this problem 
could be to incorporate the dielectric pads into phased array receive coils. 
MR spectroscopy is known to be a challenging technique to perform in the body and the 
reproducibility is often a major concern. As shown in this thesis, many variables can 
affect the reproducibility of MR spectroscopy. For example, respiratory triggering is an 
important factor that should be addressed carefully. At present, most studies use breath 
holds or a pencil beam navigator at the lung-liver interface to address this problem. 
When using breath holds, it is known that the amount of air in the lungs varies between 
subsequent breath holds resulting in variation of the location of the volume of interest 
between the breath holds and thus decreases the reproducibility. Furthermore, a breath 
hold scan is not ideal for body scans in clinical populations since patients often have 
reduced breath-holding capability. Application of a pencil beam navigator is better suited 
for MRS acquisitions since it triggers the spectroscopy sequence consistently in the same 
respiratory state without the need for breath-holds. Unfortunately even though such a 
pencil beam navigator is standard practice for body imaging the MR manufacturers do not 
offer this function for spectroscopy. The navigator can be made available by adapting the 
scanner software but not all research groups have access to the scanner software. 
Secondly, a pencil beam navigator can only track the lung liver interface in one dimension 
(lung-liver interface in feet-head direction). This may be sufficient when measuring the 
liver, but the movement of other organs like the heart and kidneys have to be estimated 
from this indirect respiratory measurement. Nonetheless, in this thesis we have shown 
that the current 1D implementation of the navigator allows for reproducible cardiac 
spectra, although it would be more optimal if the navigator could track the 3D displace-
ment of the organ of interest. Such a 3D navigator would also decrease the need for the 
subject to lie perfectly still in the scanner since it is often challenging for patients to lay 
completely still throughout an entire scan session (from the acquisition of the spectros-
copy planning scan until the end of the spectroscopy acquisition). When a patient has 
moved substantially, it can lead to incorrect lipid quantification when peri-organ adipose 
tissue becomes included in the MRS voxel due to the movement. This can be confirmed by 
acquiring an additional post-MRS plan scan or in the post processing of the separate 
averages of the spectroscopy data.
Another variable of great importance for the reproducibility of MRS is the power optimiza-
tion. If the power of the excitation is over or underestimated, the desired flip angle will not 
be reached which will result in a signal loss. This signal loss in single voxel spectroscopy 
(eg. PRESS, STEAM) is, due to the multiple refocussing pulses, much higher than most 
imaging sequences. When looking solely to the signal dependence on the flip angle for the 
STEAM it can be described by,
       (Equation 1)
where S0 is the signal when flip angles 𝛳₁-₃	=	𝜋/2.60-61 For the PRESS sequence the signal 
dependence to the flip angle is even greater due to the two 180 degree refocusing pulses. 
Here the signal equation becomes,
       (Equation 2)
where S0 is the signal when flip angle 𝛳₁ = 𝜋/2 and 𝛳₂-₃	=	𝜋.62-64 For example, when the 
deviation of the flip angle is 20% when using the PRESS sequence, this will result in a 
signal loss of approximately 22%. This loss in signal will have a strong impact on the 
reproducibility stressing the need for a good power optimization. In this thesis we 
compared the standard system “global” power optimization with “local” power optimiza-
tion. Global in this case refers to the fact that power optimization is performed by inte-
grating the signal intensity over an entire transverse slice through the heart, whereas 
local applies only to the spectroscopic VOI. Local power optimization method was per-
formed by monitoring the intensity of the water peak and incrementing the tip angles of 
the excitation pulse and the two refocusing pulses in the PRESS sequence in steps of 5% 
(range, 90%–150% of the global power optimization result), and choosing the power which 
produced the maximum signal intensity. In terms of SNR, using local rather than global 
power optimization showed a significant increase. Local power optimization requires no 
changes to the system software, and so is easy to implement in a clinical setting. We 
observed that the power underestimation from a global power measurement was 
would also decrease the need for the subject to lie perfectly still in the scanner since it is 
often challenging for patients to lay completely still throughout an entire scan session (from 
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greatest in subjects with either high body mass index or athletic subjects with high lung 
volume, but further study would be required to confirm this observation.
Even though MR spectroscopy has been used for several decades in organs like the liver 
and heart, little research has been conducted examining whether this technique can be 
applied in the kidney as well. This thesis showed that MR spectroscopy of the human 
kidney for detection of cortical triglyceride content is feasible. However, it remains 
challenging to apply renal MR spectroscopy since the limited maximum size of the 
spectroscopy voxel as well as very low lipid levels in the kidney cortex result in a low SNR 
with a subsequent need for many signal averages to get sufficient SNR. Secondly, kidney 
tissue is not homogenous with substantial anatomical and functional variation between 
cortex and medulla as well as glomeruli and tubuli. Finally, due to the close proximity of 
lipid contamination sources such as sinus and perirenal lipids, accurate voxel placement 
and reliable respiratory triggering are of great importance. To improve voxel planning, a 
fat image from a water-fat acquisition can be used since the contaminating sources are 
clearly visible. For respiratory triggering, a pencil beam navigator is preferred, although 
a 3D navigator might prove even more valuable since the kidney is relatively far from the 
lung liver interface. However, with kidney spectroscopy, small motion artefacts can still 
remain. Therefore, in post processing, averages should be analysed separately to confirm 
that none of the averages are contaminated by perirenal or sinus lipids. 
At present, clinical application of MRS is mostly limited to neurology and the prostate.65,66 
In this thesis, a main challenge of implementation of the technique was overcome; the 
reproducibility. It was shown that both in the heart, as well as the kidney it is possible to 
acquire good quality and reliable spectra. Furthermore, it was shown that in porcine 
kidneys, the MR spectroscopy triglyceride levels strongly correlated with ‘criterion 
standard’ enzymatic assessment of triglyceride content. This opens up new possibilities 
to extend the (clinical) application of body MR spectroscopy.
However, the complexity of the acquisition and post-processing also contribute to the 
difficulties in the application of body MR spectroscopy. At present, the acquisition and 
reconstruction of MR spectroscopy requires extensive knowledge about the technique to 
obtain reliable results. In order to achieve a broader implementation of body MR spec-
troscopy, MR manufacturers need to play an important role since apart from the liver 
spectroscopy, no protocols are offered by the MR manufacturers for body MR spectros-
copy. Moreover, on-scanner reconstruction and post-processing methods for spectros-
copy data are limited and in most cases, off-line post-processing and analysis of the 
spectra is required.67,68 Finally, the aforementioned 3D navigator that can track the 
separate organs could contribute to further improvement of reproducibility and support a 
wider application of body MR in general.
PART TWO: CLINICAL APPLICATIONS - METABOLIC SYNDROME
MetS is a systemic disease with a complex pathophysiology including insulin resistance, 
atherogenic dyslipidemia, hypertension, ectopic lipid accumulation, low-grade inflamma-
tion, prothrombotic state, and fibrosis resulting in end-organ damage.48 Application of the 
techniques and optimizations described in this thesis, functional and structural conse-
quences of MetS can be evaluated with MR throughout the entire body.
Using a porcine model, we demonstrated that renal triglyceride content increased over 
the metabolic spectrum in conjunction with hepatic triglycerides. Previous studies have 
shown a correlation between increased bodyweight and increased hepatic and renal 
triglyceride content in both animals and humans.53,56 We observed similar trends, with 
increasing triglyceride content in the diabetic type 2 group. Using Oil Red O staining it was 
shown that renal lipid accumulation was most prominent in renal tubuli, albeit some lipid 
staining was also observed in the glomeruli. This is in accordance with a recent study of 
human nephrectomies, where lipid droplets were predominantly found in tubule cells and 
to a lesser extent in the glomeruli.56
OVERALL CONCLUSION OF THIS THESIS
As part of the present thesis advanced MR techniques were developed, including develop-
ment and application of high dielectric materials for body MR imaging and spectroscopy, 
resulting in improved signal-to-noise ratio and reproducibility. These technical advances 





1. Despres JP, Lemieux I. Abdominal obesity and metabolic 
syndrome. Nature 2006;444(7121):881–7
2. Johnson NA, Walton DW, Sachinwalla T, et al. Noninva-
sive assessment of hepatic lipid composition: advancing 
understanding and management of fatty liver disorders. 
Hepatology. 2008;47:1513–1523.
3. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic 
resonance spectroscopy to measure hepatic triglyceride 
content: prevalence of hepatic steatosis in the general 
population. Am J Physiol Endocrinol Metab. 2005;288:E462–
E468.
4 Thomas EL, Hamilton G, Patel N, et al. Hepatic triglycer-
ide content and its relation to body adiposity: a magnetic 
resonance imaging and proton magnetic resonance 
spectroscopy study. Gut. 2005;54: 122–127.
5. van Werven JR, Hoogduin JM, Nederveen AJ, et al. 
Reproducibility of 3.0 Tesla magnetic resonance spectros-
copy for measuring hepatic fat content. J Magn Reson 
Imaging. 2009;30:444–448.
6 Machann J, Stefan N, Schick F. (1)H MR spectroscopy of 
skeletal muscle, liver and bone marrow. Eur J Radiol. 
2008;67:275–284.
7. van der Meer RW, Doornbos J, Kozerke S, et al. Metabolic 
imaging of myocardial triglyceride content: reproducibility 
of 1H MR spectroscopy with respiratory navigator gating in 
volunteers. Radiology 2007; 245:251–257.
8. Felblinger J, Jung B, Slotboom J, Boesch C, Kreis R. 
Methods and reproducibility of cardiac/respiratory 
double-triggered (1)H-MR spectroscopy of the human 
heart. Magn Reson Med 1999;42:903–910.
9. Szczepaniak LS, Dobbins RL, Metzger GJ, et al. 
Myocardial triglycerides and systolic function in humans: in 
vivo evaluation by localized proton spectroscopy and 
cardiac imaging. Magn Reson Med 2003;49:417–423.
10. Ith M, Stettler C, Xu J, Boesch C, Kreis R. Cardiac lipid 
levels show diurnal changes and long-term variations in 
healthy human subjects. NMR Biomed 2014;27:1285–1292.
11 Fuss TL, Cheng LL, Evaluation of Cancer Metabolomics 
Using ex vivo High Resolution Magic Angle Spinning 
(HRMAS) Magnetic Resonance Spectroscopy (MRS), 
Metabolites. 2016 Mar 22;6(1). pii: E11. doi: 10.3390/
metabo6010011.
12. Ulmer S1, Backens M, Ahlhelm FJ, Basic Principles and 
Clinical Applications of Magnetic Resonance Spectroscopy 
in Neuroradiology, J Comput Assist Tomogr. 2016 
Jan-Feb;40(1):1-13. doi: 10.1097/RCT.0000000000000322.
13. in ‘t Zandt H1, van Der Graaf M, Heerschap A. Common 
processing of in vivo MR spectra. NMR Biomed. 2001 
Jun;14(4):224-32.
14. Drost DJ1, Riddle WR, Clarke GD; AAPM MR Task Group 
#9. Proton magnetic resonance spectroscopy in the brain: 
report of AAPM MR Task Group #9. Med Phys. 2002 
Sep;29(9):2177-97.
15. Teeuwisse WM1, Brink WM, Webb AG. Quantitative 
assessment of the effects of high-permittivity pads in 7 
Tesla MRI of the brain. Magn Reson Med. 2012 
May;67(5):1285-93. doi: 10.1002/mrm.23108. Epub 2011 Aug 
8.
16. Brink WM, Webb AG, High permittivity pads reduce 
specific absorption rate, improve B1 homogeneity, and 
increase contrast-to-noise ratio for functional cardiac MRI 
at 3 T. Magn Reson Med. 2014 Apr;71(4):1632-40. doi: 
10.1002/mrm.24778.
17. Brink WM, van der Jagt AM, Versluis MJ, Verbist BM, 
Webb AG. High permittivity dielectric pads improve high 
spatial resolution magnetic resonance imaging of the inner 
ear at 7 T. Invest Radiol. 2014 May;49(5):271-7. doi: 10.1097/
RLI.0000000000000026.
18. Brink WM, Versluis MJ, Peeters JM, Börnert P, Webb 
AG. Passive radiofrequency shimming in the thighs at 3 
Tesla using high permittivity materials and body coil receive 









Het doel van dit proefschrift was om geavanceerde MR-technieken te ontwikkelen die 
kunnen bijdragen aan de kennis van het metabool syndroom (MetS). Dergelijke technieken 
zijn belangrijk omdat in de afgelopen jaren de incidentie van het metabool syndroom 
pandemische proporties heeft bereikt.
In het eerste deel van dit proefschrift, bestaande uit de hoofdstukken 2, 3 en 4, zijn nieuwe 
technieken ontwikkeld die toegepast kunnen worden in het afbeelden en meten van de 
organen van het bovenlichaam, ook wel genaamd “Body MR”. Body MR wordt routinematig 
uitgevoerd met MR-scanners met een veldsterkte van 1,5 T. In de afgelopen jaren is echter 
een aanzienlijk deel van deze 1,5 T-scanners vervangen door hoge veldscanners (  3 T). De 
belangrijkste reden om over te schakelen naar hoge veldscanners is dat het hogere 
magnetische veld resulteert in een grotere effectieve magnetisatie van de spins, waardoor 
de signaal-ruisverhouding (SNR) toeneemt. Desalniettemin is het in Body MR een uitda-
ging om deze toename in SNR te bereiken als gevolg van een toename van imaging-arte-
facten bij een hoger magnetisch veld.
Een van de oorzaken van deze artefacten is dat de golflengte van het zend signaal korter 
wordt wat resulteert in constructieve en deconstructieve interferentie. Dit maakt het 
moeilijker is om een homogeen zend veld te creëren dat nodig is voor een artefact vrije 
afbeelding. In hoofdstuk twee (Increasing Signal Homogeneity and Image Quality in 
Abdominal Imaging at 3 T with Very High Permittivity Materials) is dit probleem aangepakt 
door sterk diëlektrische kussens toe te passen die de variantie coëfficiënt aanzienlijk 
verminderen, waardoor een meer uniform zend veld wordt gecreëerd met behulp van een 
3 T MR-scanner. Tevens verlagen de sterk diëlektrische kussens het gemiddeld beno-
digde zend vermogen, waardoor de globale gemiddeld opgenomen vermogen (SAR) wordt 
verlaagd. Dit was het geval voor zowel de in quadratuur aangestuurde alsmede de RF 
shimmed 3 T zend spoel.
In hoofdstuk drie werd een vergelijkbare benadering (Improved Cardiac Proton Magnetic 
Resonance Spectroscopy at 3 T Using High Permittivity Pads) gebruikt om de SNR van 
cardiale MR proton spectra te verhogen. De kussens werden geoptimaliseerd met behulp 
van een eindige differentie methode in het tijd domein (FDTD) om een maximaal RF-veld in 
het kamertussenschot van het hart te verkrijgen in plaats van een homogener zend veld 
over het gehele hartgebied. In vivo vertoonden de sterk diëlektrische kussens een 
gemiddelde toename in spectrale SNR van 60%. Mits de SNR hoog genoeg is, kan deze 
winst in SNR worden geruild voor een verkorting van de acquisitietijd met een factor van 
tweeënhalf, waarbij één van de grootste problemen met MR spectroscopie wordt aange-
pakt, namelijk de relatief lange totale acquisitietijd.
Zelfs na het optimaliseren van het zendveld en de ontvangstgevoeligheid met behulp van 
de diëlektrische kussens, blijft body MR-spectroscopie technisch gezien uitdagend om 
betrouwbaar uit te voeren. Dit is gedeeltelijk te wijten aan de dynamische veldfluctuaties 
geïntroduceerd door de ademhalingsbeweging, en in het geval van het hart, de hartbewe-
ging. Verder is er een inherent lage SNR van de relevante metabolieten en een grote 
afhankelijkheid van de homogeniteit van het statische magnetische veld. Met name voor 
cardiale MR spectroscopie zijn er geen standaard (klinische) protocollen die door MR 
fabrikanten worden aangeboden. Omdat er veel parameters zijn die de spectrale kwaliteit 
aanzienlijk beïnvloeden, blijft het ontwerpen van zo’n scanprotocol een uitdaging. In 
hoofdstuk vier (Parameter Optimization for Reproducible Cardiac 1H-MR Spectroscopy at 
3 Tesla) is beschreven hoe cardiale proton MR-spectroscopie kan worden geoptimali-
seerd en de reproduceerbaarheid van deze metingen bepaald. Het geoptimaliseerde 
protocol omvat een lokaal zend vermogen optimalisatie, statisch veld homogenisatie 
(B0-shimming) met behulp van negen projecties door het shimvolume, een meet vertra-
ging van 200 ms na de R-top van het ECG, op navigator gebaseerde respiratie compensa-
tie en MOIST-wateronderdrukking. Met behulp van dit geoptimaliseerde protocol werd 
een hoge intra- (Cv = 5%) en inter-sessie (Cv = 6,5%) reproduceerbaarheid van de MTGC 
bereikt. In het tweede deel van dit proefschrift (hoofdstukken vijf, zes en zeven) zijn de 
eerder ontwikkelde technieken toegepast in klinische studies om extra inzicht te krijgen 
in de ontwikkeling / behandeling van het metabool syndroom (MetS). In hoofdstuk vijf (MR 
of Multi-Organ Involvement in the Metabolic Syndrome) werd een literatuuroverzicht van 
het MetS gegeven, met de nadruk op de primaire organen waaronder de hersenen, 
skeletspier, pancreas, hart, lever en nier. Cruciale symptomen van MetS-pathofysiologie, 
lopend van ectopische lipide accumulatie tot onherstelbare orgaan schade, kunnen 
worden geëvalueerd met behulp van verscheidene MR-technieken. Daarom zou MR van 
toegevoegde waarde kunnen zijn bij het ontrafelen van de MetS-pathofysiologie, evenals 
bij het monitoren van de van therapieën.
Op dit moment is er nog veel onbekend over hoe MetS de nier beïnvloedt. Hierdoor is er 
een sterke behoefte aan niet-invasieve hulpmiddelen om het vetgehalte van de nier te 
meten.
Hoewel spectroscopie in het hart en de lever de niet-invasieve gouden standaard is voor 
het meten van het vetgehalte, werd deze techniek nog niet toegepast op de nier. Net als 
hart- en levermetingen bemoeilijkt ademhaling de toepassing van spectroscopie in de 
nier.
Daarnaast is bij nier sprectroscopie het voxel kleiner vanwege de beperkte ruimte in de 
cortex van de nier wat resulteert in een zeer lage SNR. Ondanks deze uitdagingen wordt in 
hoofdstuk zes (Metabolic Imaging of Human Kidney Triglyceride Content: Reproducibility 
of Proton Magnetic Resonance Spectroscopy) aangetoond dat MR-spectroscopie in de nier 
kan worden uitgevoerd. Verder is aangetoond dat de navigator gebaseerde respiratie 
triggering zowel de spectrale kwaliteit als de reproduceerbaarheid aanzienlijk verbetert.
In lever- en hartspectroscopie zijn verschillende onderzoeken uitgevoerd om de MR 
spectroscopie te valideren aan de gouden standaard; biopsie. Voor zover bekend was er 
echter geen validatiestudie uitgevoerd om de nauwkeurigheid van renale MR-spectrosco-
pie te testen. In hoofdstuk zeven (Metabolic imaging of fatty kidney in diabesity: validation 
and dietary intervention) hebben we deze techniek gevalideerd met behulp van var-
kensnieren door de MR-spectroscopie lipide metingen te vergelijken met de vetbepaling 
uit biopten. De lipiden gemeten met proton MR-spectroscopie en de enzymatische test 
(biopsie) waren significant gecorreleerd (r = 0,86, p  0,0001). Bovendien werden de 
effecten van dieetinterventie op de nier lipiden gemeten. Eén groep kreeg een normaal 
dieet (groep A), één een vetrijk dieet (groep B) en een derde groep volgde hetzelfde 
vetrijke dieet gecombineerd met een lage dosis streptozocine (groep C) om insuline-onaf-
hankelijke diabetes te induceren. Na het 9-maanden durende dieet waren de renale 
lipiden in groep C (hoog-lipidedieet gecombineerd met streptozocine) significant hoger in 
vergelijking met groep A (normaal dieet). Nierlipiden waren niet significant verschillend 
tussen groep B (hoog lipidedieet) en groep A (gewoon dieet).
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